Diabetes Health Economics Bibliography

This page lists the resources published in the diabetes literature which deal with economic issues. It was constructed by searching Medline and Current Contents for papers with diabetes and economics, cost-effectiveness, cost-benefit, and costs as keywords. Items also include papers and book chapters, etc. provided to me. The contents include papers where diabetes has been the central or major focus of the manuscript.

If you would like to include a reference in the bibliography, please submit the details of the reference to Thomas Songer at tjs+@pitt.edu.

This bibliography has been updated through December 2000


Australian Institute of Health and Welfare, Dixon T. Costs of diabetes in Australia, 2000-01. Bulletin No. 26. AIHW Cat. No. AUS 59. Canberra, AIHW, 2005. Available at http://www.aihw.gov.au/publications/aus/bulletin26/bulletin26.pdf


Ohinmaa A, Jacobs P, Simpson S, Johnson JA. The projection of prevalence and cost of diabetes in Canada: 2000 to 2016. Canadian Journal of Diabetes 28(2), 2004. Available online at http://www.diabetes.ca/Files/JohnsonCJDJune2004.pdf


American Diabetes Association. Economic costs of diabetes in the U.S. in 2002. Diabetes Care 26(3):917-932, 2003. Available online at http://www.house.gov/degette/diabetes/docs/ADACostArticle.pdf


Anonymous: Tight glucose control is cost effective in diabetes. BMJ 320:D, 2000

Allenet B. Paree F. Lebrun T. Carr L. Posnett J. Martini J. Yvon C. Cost-effectiveness modeling of Dermagraft for the treatment of diabetic foot ulcers in the french context. Diabetes & Metabolism. 26(2):125-32, 2000 Apr.

Allicar MP. Megas F. Houzard S. Baroux A. Le Thai F. Augendre-Ferrante B. [Frequency and costs of hospital stays for hypoglycemia in France in 1995]. [French] Presse Medicale. 29(12):657-61, 2000 Apr 1.

Almbrand B. Johannesson M. Sjostrand B. Malmberg K. Ryden L. Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study [see comments]. European Heart Journal. 21(9):733-9, 2000 May.

Brown JB, Palmer AJ, Bisgaard P, Chan W, Pedula K, Russell A: The Mt. Hood challenge: cross-testing two diabetes simulation models. Diabetes Res Clin Pract 50 Suppl 3:S57-64, 2000

Brown JB, Russell A, Chan W, Pedula K, Aickin M: The global diabetes model: user friendly version 3.0. Diabetes Res Clin Pract 50 Suppl 3:S15-46, 2000

Brown JB: Computer models of diabetes: almost ready for prime time. Diabetes Res Clin Pract 50 Suppl 3:S1-3, 2000

Caro JJ. Klittich WS. Raggio G. Kavanagh PL. O'Brien JA. Shomphe LA. Flegel KM. Copley-Merriman C. Sigler C. Economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment of type 2 diabetes. Clinical Therapeutics. 22(1):116-27, 2000 Jan.

Carpentier B. Pradines S. Benhamou PY. Halimi S. [Health costs associated with the diabetic foot in developed countries.A plea for the creation of health care networks]. [French] Diabetes & Metabolism. 26(1):75-80, 2000 Feb.

Chin MH. Zhang JX. Merrell K. Specialty differences in the care of older patients with diabetes [see comments]. Medical Care. 38(2):131-40, 2000 Feb.

Ciechanowski PS, Katon WJ, Russo JE: Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 160:3278-85, 2000

Clark WF. Churchill DN. Forwell L. Macdonald G. Foster S. To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy. CMAJ. 162(2):195-8, 2000 Jan 25.

Culler SD, Weintraub WS, Shaw LJ, Becker ER: Hospital resource consumption in patients with diabetes and multivessel coronary disease undergoing revascularization. Am J Manag Care 6:217-29, 2000

de Lissovoy G, Ganoczy DA, Ray NF: Relationship of hemoglobin A1c, age of diabetes diagnosis, and ethnicity to clinical outcomes and medical costs in a computer-simulated cohort of persons with type 2 diabetes. Am J Manag Care 6:573-84, 2000

Detournay B, Fagnani F, Pribil C, Eschwege E: [Medical resources consumption of type 2 diabetics in France in 1998] [French]. Diabetes Metab 26:225-31, 2000

Dranitsaris G, Longo CJ, Grossman LD: The economic value of a new insulin preparation, Humalog Mix 25. Measured by a willingness-to-pay approach. Pharmacoeconomics 18:275-87, 2000

Duren-Winfield VT, Bell RA, Anderson RT, Frank JH, Konen JC, Goff DC Jr: Project IDEAL. Improving Diabetes Education, Access to care and Living. A plan to reduce the burden of diabetes in North Carolina. N C Med J 61:420-2, 2000

Elliott WJ. Weir DR. Black HR. Cost-effectiveness of the lower treatment goal (of JNC VI) for diabetic hypertensive patients. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Archives of Internal Medicine. 160(9):1277-83, 2000 May 8.

Evans JM, MacDonald TM, Leese GP, Ruta DA, Morris AD: Impact of type 1 and type 2 diabetes on patterns and costs of drug prescribing: a population-based study. Diabetes Care 23:770-4, 2000

Gabbe SG, Holing E, Temple P, Brown ZA: Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol 182:1283-91, 2000

Goyder EC, McNally PG, Botha JL: Inequalities in access to diabetes care: evidence from a historical cohort study. Qual Health Care 9:85-9, 2000

Gozzoli V, Palmer AJ, Brandt A, Weiss C, Piehlmeier W, Landgraf R, Renner R: No Title Available [German]. Dtsch Med Wochenschr 125:1154-9, 2000

Gray A. Raikou M. McGuire A. Fenn P. Stevens R. Cull C. Stratton I. Adler A. Holman R. Turner R. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group. BMJ. 320(7246):1373-8, 2000 May 20.

Grover SA, Coupal L, Zowall H, Dorais M: Cost-effectiveness of treating hyperlipidemia in the presence of diabetes : who should be treated? Circulation 102:722-7, 2000

Harrington C, Zagari MJ, Corea J, Klitenic J: A cost analysis of diabetic lower-extremity ulcers. Diabetes Care 23:1333-8, 2000

Henriksson F, Agardh CD, Berne C, Bolinder J, Lonnqvist F, Stenstrom P, Ostenson CG, Jonsson B: Direct medical costs for patients with type 2 diabetes in Sweden. J Intern Med 248:387-396, 2000

Jacobs P, Blanchard JF, James RC, Depew N: Excess costs of diabetes in the Aboriginal population of Manitoba, Canada. Can J Public Health 91:298-301, 2000

James M. Turner DA. Broadbent DM. Vora J. Harding SP. Cost effectiveness analysis of screening for sight threatening diabetic eye disease [see comments]. BMJ. 320(7250):1627-31, 2000 Jun 17.

Junger C. Rathmann W. Giani G. [Prescribing behavior of primary care physicians in diabetes therapy: effect of drug budgeting]. [German] Deutsche Medizinische Wochenschrift. 125(5):103-9, 2000 Feb 4.

Karter AJ, Ferrara A, Darbinian JA, Ackerson LM, Selby JV: Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care 23:477-83, 2000

Kitzmiller JL. Cost analysis of diagnosis and treatment of gestational diabetes mellitus. [Review] Clinical Obstetrics & Gynecology. 43(1):140-53, 2000 Mar.

Klonoff DC, Schwartz DM: An economic analysis of interventions for diabetes [Review]. Diabetes Care 23:390-404, 2000

Krein SL. Hayward RA. Pogach L. BootsMiller BJ. Department of Veterans Affairs' Quality Enhancement Research Initiative for Diabetes Mellitus. [Review] Medical Care. 38(6 Suppl 1):I38-48, 2000 Jun.

Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BH, Rutten G: The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Anglo-Danish-Dutch Study of Intensive Treatment In People with Screen Detected Diabetes in Primary Care. Int J Obes Relat Metab Disord 24 Suppl 3:S6-11, 2000

Lee DS, Remington P, Madagame J, Blustein J: A cost analysis of community screening for diabetes in the central Wisconsin Medicare population (results from the MetaStar pilot project in Wausau). WMJ 99:39-43, 2000

Liebl A, Goertz A, Henkel B, Spannheimer A: [Costly type 2 diabetes mellitus. Does diabetes cost 20 billion per year?] [German]. MMW Fortschr Med 142:39-42, 2000

Marshall CL. Bluestein M. Briere E. Chapin C. Darling B. Davis K. Davis T. Gersten J. Harris C. Hodgin A. Larsen W. Mabb D. Rigberg H. Watson D. Krishnaswami V. Improving outpatient diabetes management through a collaboration of six competing, capitated Medicare managed care plans. American Journal of Medical Quality. 15(2):65-71, 2000 Mar-Apr.

Meltzer D. Egleston B. Stoffel D. Dasbach E. Effect of future costs on cost-effectiveness of medical interventions among young adults: the example of intensive therapy for type 1 diabetes mellitus. Medical Care. 38(6):679-85, 2000 Jun.

Moore P. Type 2 diabetes is a major drain on resources [news]. BMJ. 320(7237):732, 2000 Mar 18.

Nichols GA, Glauber HS, Brown JB: Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis. Diabetes Care 23:1654-9, 2000

Overland J, Yue DK, Mira M: The pattern of diabetes care in New South Wales: a five-year analysis using Medicare occasions of service data. Aust N Z J Public Health 24:391-5, 2000

Palmer AJ. Weiss C. Sendi PP. Neeser K. Brandt A. Singh G. Wenzel H. Spinas GA. The cost-effectiveness of different management strategies for type I diabetes: a Swiss perspective. Diabetologia. 43(1):13-26, 2000 Jan.

Palmer AJ, Sendi PP, Spinas GA: Applying some UK Prospective Diabetes Study results to Switzerland: the cost-effectiveness of intensive glycaemic control with metformin versus conventional control in overweight patients with type-2 diabetes. Schweiz Med Wochenschr 130:1034-40, 2000

Palmer AJ, Brandt A, Gozzoli V, Weiss C, Stock H, Wenzel H: Outline of a diabetes disease management model: principles and applications. Diabetes Research and Clinical Practice 50 (Suppl. 3):S47-S56, 2000

Piette JD: Perceived access problems among patients with diabetes in two public systems of care. J Gen Intern Med 15:797-804, 2000

Polak BC, Crijns H: [Detailed analysis of the social costs of diabetes mellitus (letter; comment)] [Dutch]. Ned Tijdschr Geneeskd 144:1556-7, 2000

Price P, Harding K: The impact of foot complications on health-related quality of life in patients with diabetes. J Cutan Med Surg 4:45-50, 2000

Ragnarson Tennvall G, Apelqvist J, Eneroth M: The inpatient care of patients with diabetes mellitus and foot ulcers. A validation study of the correspondence between medical records and the Swedish Inpatient Registry with the consequences for cost estimations. Journal of Internal Medicine 248:397-405, 2000

Reunanen A, Kangas T, Martikainen J, Klaukka T: Nationwide survey of comorbidity, use, and costs of all medications in Finnish diabetic individuals. Diabetes Care 23:1265-71, 2000

Ricordeau P, Weill A, Vallier N, Bourrel R, Fender P, Allemand H: [The cost of diabetes in mainland France] [French]. Diabetes Metab 26 Suppl 6:25-38, 2000

Salas M, Bubolz T, Caro JJ: Impact of physical functioning of health status on hospitalizations, physician visits, and costs in diabetic patients. Arch Med Res 31:223-7, 2000

Sharma S, Brown GC, Brown MM, Hollands H, Shah GK: The cost-effectiveness of grid laser photocoagulation for the treatment of diabetic macular edema: results of a patient-based cost-utility analysis. Curr Opin Ophthalmol 11:175-9, 2000

Shobhana R. Rama Rao P. Lavanya A. Williams R. Vijay V. Ramachandran A. Expenditure on health care incurred by diabetic subjects in a developing country--a study from southern India. Diabetes Research & Clinical Practice. 48(1):37-42, 2000 Apr.

Stevens R, Adler A, Gray A, Briggs A, Holman R: Life-expectancy projection by modelling and computer simulation (UKPDS 46). Diabetes Research and Clinical Practice 50 (Suppl. 3):S5-S13, 2000

Tennvall GR, Apelqvist J, Eneroth M: Costs of deep foot infections in patients with diabetes mellitus. Pharmacoeconomics 18:225-38, 2000

van Os N. Niessen LW. Koopmanschap MA. van der Lei J. Detailed analysis of the societal costs of diabetes mellitus. [Dutch] Nederlands Tijdschrift voor Geneeskunde. 144(18):842-6, 2000 Apr 29.

van Os N, Niessen LW, Bilo HJ, Casparie AF, van Hout BA: Diabetes nephropathy in the Netherlands: a cost effectiveness analysis of national clinical guidelines. Health Policy 51:135-47, 2000

Vijan S. Hofer TP. Hayward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA. 283(7):889-96, 2000 Feb 16.

Wake N. Hisashige A. Katayama T. Kishikawa H. Ohkubo Y. Sakai M. Araki E. Shichiri M. Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study. Diabetes Research & Clinical Practice. 48(3):201-10, 2000 Jun.


Adelman MD. Glycemic control and quality of life in patients with type 2 diabetes [letter; comment]. JAMA. 281(21):1985; discussion 1986, 1999 Jun 2.

Amin SP, Mullins CD, Duncan BS, Blandford L: Direct health care costs for treatment of diabetes mellitus and hypertension in an IPA-group-model HMO. Am J Health Syst Pharm 56:1515-20, 1999

Anonymous: Diabetes: staged group education is effective and cost-efficient. Med Manag Netw 7:8, 16, 1999

Bhattacharyya SK. Else BA. Medical costs of managed care in patients with type 2 diabetes mellitus. Clinical Therapeutics. 21(12):2131-42, 1999 Dec.

Black SA. Jakobi PL. Rush RD. DiNuzzo AR. Garcia D. Ethnic variation in the health burden of self-reported diabetes in adults aged 75 and older. Ethnicity & Disease. 9(1):22-32, 1999 Winter.

Bradley C. Todd C. Gorton T. Symonds E. Martin A. Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Quality of Life Research. 8(1-2):79-91, 1999.

Brown JB. Nichols GA. Glauber HS. Bakst A. Ten-year follow-up of antidiabetic drug use, nonadherence, and mortality in a defined population with type 2 diabetes mellitus. Clinical Therapeutics. 21(6):1045-57, 1999 Jun.

Brown JB. Nichols GA. Glauber HS. Bakst AW. Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care. 22(7):1116-24, 1999 Jul.

Brown JB. Pedula KL. Bakst AW. The progressive cost of complications in type 2 diabetes mellitus. Archives of Internal Medicine. 159(16):1873-80, 1999 Sep 13.

Crijns H. Casparie AF. Hendrikse F. Continuous computer simulation analysis of the cost-effectiveness of screening and treating diabetic retinopathy. International Journal of Technology Assessment in Health Care. 15(1):198-206, 1999 Winter.

Detournay B. Vauzelle-Kervroedan F. Charles MA. Forhan A. Fagnani F. Fender P. Eschwege E. Epidemiology, management and costs of type 2 diabetes in France in 1998. [Review] [French] Diabetes & Metabolism. 25(4):356-65, 1999 Sep.

Dornberger S, Stone D, Elliott-Bynum S: Examining economic improvements in managing diabetes in the nursing home. Director 7:152-4, 157, 1999

Dougherty G. Schiffrin A. White D. Soderstrom L. Sufrategui M. Home-based management can achieve intensification cost-effectively in type I diabetes. Pediatrics 103(1):122-128, 1999 Jan.

Douzdjian V. Escobar F. Kupin WL. Venkat KK. Abouljoud MS. Cost-utility analysis of living-donor kidney transplantation followed by pancreas transplantation versus simultaneous pancreas-kidney transplantation. Clinical Transplantation. 13(1 Pt 1):51-8, 1999 Feb.

Engelgau MM. The cost-effectiveness of screening for type 2 diabetes (vol 280, pg 1757, 1998). [Correction, Addition] Journal of the American Medical Association 281(4):325, 1999 Jan 27.

Golan L. Birkmeyer JD. Welch HG. The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors [see comments]. Annals of Internal Medicine. 131(9):660-7, 1999 Nov 2.

Goyder E. Irwig L. Screening for type 2 diabetes [letter; comment]. JAMA. 281(21):1986-7; discussion 1987-8, 1999 Jun 2.

Grieve R, Beech R, Vincent J, Mazurkiewicz J: Near patient testing in diabetes clinics: appraising the costs and outcomes. Health Technol Assess 3:1-74, 1999

Harris MI: Racial and ethnic differences in health insurance coverage for adults with diabetes. Diabetes Care 22:1679-82, 1999

Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM: Identifying persons with diabetes using Medicare claims data. Am J Med Qual 14:270-7, 1999

Henriksson F, Agardh CD, Berne C, Bolinder J, Jonsson B: [Health economics analysis of diabetes is necessary. It facilitates decision-making and international comparison] [Swedish]. Lakartidningen 96:3915-6, 3919, 1999

Herman WH. Alexander CM. Cook JR. Boccuzzi SJ. Musliner TA. Pedersen TR. Kjekshus J. Pyorala K. Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study [see comments]. Diabetes Care. 22(11):1771-8, 1999 Nov.

Herman WH, Janz NK, Becker MP, Charron-Prochownik D: Diabetes and pregnancy. Preconception care, pregnancy outcomes, resource utilization and costs. J Reprod Med 44:33-8, 1999

Hodgson TA. Cohen AJ. Medical care expenditures for diabetes, its chronic complications, and its comorbidities. Preventive Medicine. 29(3):173-86, 1999 Sep.

Hofer TP. Hayward RA. Greenfield S. Wagner EH. Kaplan SH. Manning WG. The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease [see comments]. JAMA. 281(22):2098-105, 1999 Jun 9.

Jonsson B. Cook JR. Pedersen TR. The cost-effectiveness of lipid lowering in patients with diabetes: results from the 4S trial. Diabetologia. 42(11):1293-301, 1999 Nov.

Junger C. Rathmann W. Giani G. [Drug prescribing in primary health care for diabetic and non-diabetic patients: effect of therapeutic drug budgeting]. [German] Gesundheitswesen. 61(12):607-13, 1999 Dec.

Kiberd BA. Jindal KK. Should all Pima Indians with type 2 diabetes mellitus be prescribed routine angiotensin-converting enzyme inhibition therapy to prevent renal failure?. Mayo Clinic Proceedings. 74(6):559-64, 1999 Jun.

Kibriya MG. Ali L. Banik NG. Khan AK. Home monitoring of blood glucose (HMBG) in Type-2 diabetes mellitus in a developing country. Diabetes Research & Clinical Practice. 46(3):253-7, 1999 Dec.

Kilburg A. Bruchhausen Y. Thomas J. Rychlik R. [A cost analysis of diagnostic screening for the differentiation of type-1 and type-2 diabetics aged 30 to 45. A health economics modelling calculation]. [German] Deutsche Medizinische Wochenschrift. 124(50):1510-7, 1999 Dec 17.

Krop JS, Saudek CD, Weller WE, Powe NR, Shaffer T, Anderson GF: Predicting expenditures for Medicare beneficiaries with diabetes. A prospective cohort study from 1994 to 1996. Diabetes Care 22:1660-6, 1999

Levetan CS. Passaro MD. Jablonski KA. Ratner RE. Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care. 22(11):1790-5, 1999 Nov.

Mehta SS. Suzuki S. Glick HA. Schulman KA. Determining an episode of care using claims data. Diabetic foot ulcer. Diabetes Care. 22(7):1110-5, 1999 Jul.

MacKeigan LD. O'Brien BJ. Oh PI. Holistic versus composite preferences for lifetime treatment sequences for type 2 diabetes. Medical Decision Making. 19(2):113-21, 1999 Apr-Jun.

Meyer-Heintze V. Diabetic foot from the social medicine viewpoint. [German] Zentralblatt fur Chirurgie. 124 Suppl 1:45-8, 1999.

Mikulecky M. Michalkova D. Spatial clustering of childhood IDDM prevalence in Slovakia 1985-95: a socio-economic issue?. Journal of Pediatric Endocrinology & Metabolism. 12(5):677-9, 1999 Sep-Oct.

Mukamel DB. Bresnick GH. Wang Q. Dickey CF.
Barriers to compliance with screening guidelines for diabetic retinopathy [see comments]. Ophthalmic Epidemiology. 6(1):61-72, 1999 Mar.

Oster G. Thompson D. Edelsberg J. Bird AP. Colditz GA. Lifetime health and economic benefits of weight loss among obese persons. American Journal of Public Health. 89(10):1536-42, 1999 Oct.

Pagano E, Brunetti M, Tediosi F, Garattini L: Costs of diabetes. A methodological analysis of the literature. Pharmacoeconomics 15:583-95, 1999

Porta M. Rizzitiello A. Tomalino M. Trento M. Passera P. Minonne A. Pomero F. Gamba S. Castellazzi R. Montanaro M. Sivieri R. Orsi R. Bondonio P. Molinatti GM. Comparison of the cost-effectiveness of three approaches to screening for and treating sight-threatening diabetic retinopathy. Diabetes & Metabolism. 25(1):44-53, 1999 Mar.

Pritchard DA. Hyndman J. Taba F. Nutritional counselling in general practice: a cost effective analysis. Journal of Epidemiology & Community Health. 53(5):311-6, 1999 May.

Ramsdell JW, Grossman JA, Stephens JM, Botteman MF, Arocho R: A short-term cost-of-treatment model for type 2 diabetes: comparison of glipizide gastrointestinal therapeutic system, metformin, and acarbose. Am J Manag Care 5:1007-24, 1999

Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Wagner EH: Patient-level estimates of the cost of complications in diabetes in a managed-care population. Pharmacoeconomics 16:285-95, 1999

Rathmann W. Haastert B. Giani G. [Drug prescriptions and costs in diabetic polyneuropathy]. [German] Deutsche Medizinische Wochenschrift. 124(22):681-6, 1999 Jun 4.

Reichard P, Alm C, Andersson E, Warn I, Rosenqvist U: [Intensified insulin treatment is cost-effective] [Swedish]. Lakartidningen 96:172-4, 1999

Shirasaya K. Miyakawa M. Yoshida K. Takahashi E. Shimada N. Kondo T. Economic evaluation of alternative indicators for screening for diabetes mellitus. Preventive Medicine. 29(2):79-86, 1999 Aug.

Simmons D. Peng A. Cecil A. Gatland B. The personal costs of diabetes: a significant barrier to care in South Auckland. New Zealand Medical Journal. 112(1097):383-5, 1999 Oct 8.

Smith TL, Melfi CA, Kesterson JA, Sandmann BJ, Kotsanos JG: Direct medical charges associated with myocardial infarction in patients with and without diabetes. Med Care 37:AS4-11, 1999

Taboulet F. Latry P. Fontaine S. Timmerman L. [Impact of demographic changes on drug utilization related to diabetes in Aquitaine]. [French] Cahiers de Sociologie et de Demographie Medicales. 39(2-3):253-69, 1999 Apr-Sep.

Vauzelle-Kervroedan F. Forhan A. Javoy F. Fender P. Eschwege E. Pharmacoepidemiology of diabetes: contribution of a survey of health insurance cases. [French] Diabetes & Metabolism. 25(2):163-71, 1999 Jun.


American Diabetes Association . Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 21(2):296-309, 1998.

Bachman KH. Cost of Troglitazone therapy [letter]. Archives of Internal Medicine158(9):1038, 1998 May 11.

Banz K. Dinkel R. Hanefeld M. Schwanebeck U. Evaluation of the potential clinical and economic effects of body weight stabilisation with Acarbose in patients with Type 2 diabetes mellitus - A decision-analytical approach. Pharmacoeconomics 13(4):449-459, 1998 Apr.

Brenner G. Altenhofen L. Structured documentation for quality management in patients with diabetes mellitus. [German] Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung 92(2):123-30, 1998 Mar.

Brown RR. Cost-effectiveness and clinical outcomes of metformin or insulin add-on therapy in adults with type 2 diabetes. American Journal of Health-System Pharmacy 55(Suppl 4):S24-S27, 1998 Dec 15.

Burnett S. Hurwitz B. Davey C. Ray J. Chaturvedi N. Salzmann J. Yudkin JS. The implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner city district of North London - A quality of care study. Diabetic Medicine 15(11 Suppl 3):S 38-S 43, 1998 Nov.

Clua Espuny JL. Queralt Tomas ML. Castan Cameo S. Evaluation of the effectiveness of metabolic self-control through direct dispensation of diagnostic strips to type 2 diabetic patients. [Spanish] Atencion Primaria 21(4):193-8, 1998 Mar 15.

Costa B. Estopa A. Borras J. Sabate A. Medication consumption in diabetes mellitus (VI) - Economics and effectiveness of insulin and sulfonylurea combination therapy compared with conventional two daily doses [Spanish]. Medicina Clinica 111(15):568-572, 1998 Nov 7.

Currie CJ, Morgan CL, Peters JR. The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes. Diabetes Care. 21(1):42-48, 1998 Jan.

Currie CJ. Peters JR. The demand and financial cost of hospital care for diabetes mellitus and its related complications. [Editorial] Diabetic Medicine 15(6):449-51, 1998 Jun.

Daneman D. Frank M. Defining quality of care for children and adolescents with Type 1 diabetes. Acta Paediatrica 87(Suppl 425):11-19, 1998 Oct.

Davey P. Grainger D. Macmillan J. Rajan N. Aristides M. Dobson M. Economic evaluation of insulin lispro versus neutral (regular) insulin therapy using a willingness to pay approach. Pharmacoeconomics 13(3):347-358, 1998 Mar.

Donaldson C. Narayan KM. The cost of diabetes. A useful statistic?. [Letter] Diabetes Care 21(8):1370-1, 1998 Aug.

Dougherty GE. Soderstrom L. Schiffrin A. An economic evaluation of home care for children with newly diagnosed diabetes: results from a randomized controlled trial. Medical Care 36(4):586-98, 1998 Apr.

Douzdjian V. Ferrara D. Silvestri G. Cost-utility analysis of pancreas transplantation compared to other treatment options for type I diabetics with end-stage renal disease. Transplantation Proceedings 30(2):278, 1998 Mar.

Douzdjian V. Ferrara D. Silvestri G. Treatment strategies for insulin-dependent diabetics with ESRD - a cost-effectiveness decision analysis model. American Journal of Kidney Diseases 31(5):794-802, 1998

Eastman RC. Cost-effectiveness of treatment of Type 2 diabetes. [Letter] Diabetes Care 21(3):464-465, 1998 Mar

Elwyn GJ. Vaughan NJA. Stott NCH. District diabetes registers - more trouble than they're worth. Diabetic Medicine 15(11 Suppl 3):S44-S48, 1998 Nov.

Engelgau MM. Narayan KMV. Thompson TJ. Boyle JP. Williamson DF. Manninen DL. Dong FB. Orians CE. Dasbach EJ. Teutsch SM. Eastman R. Herman WH. Songer TJ. The cost-effectiveness of screening for Type 2 diabetes. Journal of the American Medical Association. 280(20):1757-1763, 1998 Nov 25.

Gerber RA. Liu G. Mccombs JS. Impact of pharmacist consultations provided to patients with diabetes on health care costs in a health maintenance organization. American Journal of Managed Care 4(7):991-1000, 1998 Jul.

Ginsberg BH. Tan MH. Mazze R. Bergelson A. Staged diabetes management: computerizing a disease state management program. Journal of Medical Systems 22(2):77-87, 1998 Apr.

Griffin S. Diabetes care in general practice: meta-analysis of randomised control trials. BMJ 317(7155):390-6,1998 Aug 8.

Goold SD. Vijan S. Normative issues in cost-effectiveness analysis. Journal of Laboratory & Clinical Medicine 132(5):376-382, 1998 Nov.

Guo JJ. Gibson JT. Gropper DM. Oswald SL. Barker KN. Empiric investigations on direct costs-of-illness and health care utilization of medicaid patients with diabetes mellitus. American Journal of Managed Care 4(10):1433-1446, 1998 Oct.

Hahl J. Simell T. Ilonen J. Knip M. Simell O. Costs of predicting IDDM. Diabetologia 41(1):79-85, 1998 Jan.

Henriksson F, Jonsson B. Diabetes; the cost of illness in Sweden. Journal of Internal Medicine 244(6):461-468, 1998 Dec.

Herman WH. Economic impact of intensive insulin therapy in IDDM. [Review] [French] Journees Annuelles de Diabetologie de l Hotel-Dieu 241-8, 1998.

Herman WH. Eastman RC. The effects of treatment on the direct costs of diabetes. Diabetes Care 21(Suppl 3):C19-C24, 1998 Dec.

Hernaezortega MC. Sotopedre E. Vazquez JA. Gutierrez MA. Asua J. Study of the efficiency of a non-mydriatic retinal camera for the diagnosis of diabetic retinopathy [Spanish]. Revista Clinica Espanola 198(4):194-199, 1998 Apr.

Holzer SE. Camerota A. Martens L. Cuerdon T. Crystal-Peters J. Zagari M. Costs and duration of care for lower extremity ulcers in patients with diabetes [published erratum appears in Clin Ther 1998 Mar-Apr;20(2):373]. Clinical Therapeutics 20(1):169-81, 1998 Jan-Feb.

Hood SC. Annemans L. Ruttenvanmolken M. A short-term cost-effectiveness model for oral antidiabetic medicines in Europe. Pharmacoeconomics 13(3):317-326, 1998 Mar

Jonsson B. The economic impact of diabetes. Diabetes Care 21(Suppl 3.):C7-C10, 1998 Dec.

Kiberd BA, Jindal KK. Routine treatment of insulin-dependent diabetic patients with ACE inhibitors to prevent renal failure; an economic evaluation. American Journal of Kidney Diseases. 31(1):49-54, 1998 Jan.

Kitzmiller JL. Elixhauser A. Carr S. Major CA. Deveciana M. Dangkilduff L. Weschler JM. Assessment of costs and benefits of management of gestational diabetes mellitus. Diabetes Care 21(Suppl 2):B 123-B 130, 1998

Kortt MA. Langley PC. Cox ER. A Review of cost-of-illness studies on obesity. [Review] Clinical Therapeutics 20(4):772-779, 1998 Jul-Aug.

Krop JS. Powe NR. Weller WE. Shaffer TJ. Saudek CD. Anderson GF. Patterns of expenditures and use of services among older adults with diabetes. Implications for the transition to capitated managed care. Diabetes Care 21(5):747-52, 1998 May.

Lehmann DF. Medicis JJ. A pharmacoeconomic model to aid in the allocation of ambulatory clinical pharmacy service. Journal of Clinical Pharmacolog 38(9):783-791, 1998.

Lybarger JA. Lee R. Vogt DP. Perhac RM. Spengler RF. Brown DR. Medical costs and lost productivity from health conditions at volative organic compound-contaminated Superfund sites. Environmental Research 79(1):9-19, 1998 Oct.

MacKeigan LD: A short term cost-effectiveness model for oral antidiabetic medicines in Europe. Pharmacoeconomics 14:709-10, 1998

Martin JD, Yidegiligne HM: The cost-effectiveness of a retinal photography screening program for preventing diabetic retinopathy in the First Nations diabetic population in British Columbia, Canada. Int J Circumpolar Health 57 Suppl 1:379-82, 1998

Muller UA. Muller R. Starrach A. Hungerdathe W. Schiel R. Jorgens V. Grusser M. Should insulin therapy in Type 2 diabetic patients be started on an out- or inpatient basis; results of a prospective controlled trial using the same treatment and teaching programme in ambulatory care and a university hospital. Diabetes & Metabolism 24(3):251-255, 1998 Jun.

O'Brien JA. Shomphe LA. Kavanagh PL. Raggio G. Caro JJ. Direct medical costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care 21(7):1122-8, 1998 Jul.

Ollendorf DA. Kotsanos JG. Wishner WJ. Friedman M. Cooper T. Bittoni M. Oster G. Potential economic benefits of lower-extremity amputation prevention strategies in diabetes. Diabetes Care 21(8):1240-5, 1998 Aug.

Penfornis A. Millot L. Initiating insulin treatment in insulin-requiring type 2 diabetic patients: comparative efficiency and cost of outpatient and inpatient management. INNOV Study Group. Diabetes & Metabolism 24(2):137-42, 1998 Apr.

Phillips CJ. The economic implications of implementing evidence-based diabetic treatment strategies. [Review] International Journal of Clinical Practice 52(3):181-7, 1998 Apr-May.

Pogach LM. Hawley G. Weinstock R. Sawin C. Schiebe H. Cutler F. Zieve F. Bates M. Repke D. Diabetes prevalence and hospital and pharmacy use in the Veterans Health Administration (1994). Use of an ambulatory care pharmacy-derived database. Diabetes Care 21(3):368-73, 1998 Mar.

Postma MJ. Jager JC. Ruwaard D. Vanloy NCM. Leidl RM. Disease-staging for modelling current and future health care impact of diseasae; Illustrations for diabetes mellitus and AIDS. Health Policy 43(1):45-54, 1998 Jan.

Rathmann W. Haastert B. Roseman JM. Gries FA. Giani G. Prescription drug use and costs among diabetic patients in primary health care practices in Germany. Diabetes Care 21(3):389-97, 1998 Mar.

Reiber GE. Lipsky BA. Gibbons GW. The burden of diabetic foot ulcers. American Journal of Surgery 176(2A Suppl S):S 5-S 10, 1998 Aug.

Rubin RJ. Dietrich KA. Hawk AD. Clinical and economic impact of implementing a comprehensive diabetes management program in managed care. Journal of Clinical Endocrinology & Metabolism 83(8):2635-42, 1998 Aug.

Rubio JA. Alvarez J. Economic costs of diabetes mellitus: critical review and cost-benefit evaluation of proposed strategies for its reduction. [Spanish] Atencion Primaria 22(4):239-55, 1998

Rudolph BA. Miller N. Cost of care for diabetes in Wisconsin hospitals and ambulatory surgery centers in 1996. Wisconsin Medical Journal 97(3):55-7, 1998 Mar.

Scheen AJ. Lefebvre PJ. Pharmaco-economics of type 2 diabetes. [Review][French] Revue Medicale de Liege 53(5):285-9, 1998 May.

Schrock LE. Review of Cost Efficiency and Efficacy of Delivering a Diabetes Education Program in a Southwest Rural Health Care Facility. [Review] Diabetes Educator 24(4):485-492, 1998.

Schuster MW. Chauhan SP. McLaughlin BN. Perry KG Jr. Morrison JC. Comparison of insulin regimens and administration modalities in pregnancy complicated by diabetes. Journal of the Mississippi State Medical Association 39(6):208-12, 1998 Jun.

Segal L, Dalton AC, Richardson J. Cost-effectiveness of the primary prevention of Type 2 diabetes mellitus. Health Promotion International 13(3):197-209, 1998 Sept.

Stearne MR. Palmer SL. Hammersley MS. et al. Cost-effectiveness analysis of improved blood pressure control in hypertensive patients with Type 2 diabetes - UKPDS 40. British Medical Journal 317 (7160):720-726, 1998.

Testa MA. Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. JAMA 280(17):1490-6, 1998 Nov 4.

Thompson D. Edelsberg J. Kinsey KL. Oster G. Estimated economic costs of obesity to US business. American Journal of Health Promotion 13(2):120-127, 1998 Nov-Dec.

Tomar RH, Lee S, Wu SY, Klein R, Klein BE, Moss SE, Fryback DG, Tollios JL, Sainfort F. Disease progression and cost of insulin-dependent diabetes mellitus: development and application of a simulation model. J Soc Health Syst 5(4):24-37, 1998.

UK Prospective Diabetes Study Group. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 317(7160):720-6, 1998 Sep 12.

Vinicor F. Diabetes Mellitus and Asthma - Twin challenges for Public Health and Managed Care Systems. American Journal of Preventive Medicine 14(3 Suppl S):87-92, 1998 Apr.

Vinicor F. The public health burden of diabetes and the reality of limits. Diabetes Care 21(Suppl 3):C15-C18, 1998 Dec.

Wolf AM. Colditz GA. Current estimates of the economic cost of obesity in the United States. Obesity Research 6(2):97-106, 1998 Mar.

Wu SY. Sainfort F. Tomar RH. Tollios JL. Fryback DG. Klein R. Klein BEK. Development and application of a model to estimate the impact of Type 1 diabetes on health-related quality of life. Diabetes Care 21(5):725-731, 1998 May

Wu SYB. Lung BCH. Chang S. Lee SC. Critchley JAJH. Chan JCN. Evaluation of drug usage and expenditure in a hospital diabetes clinic. Journal of Clinical Pharmacy & Therapeutics 23(1):49-56, 1998 Feb.


Anonymous. Suffering and costs of diabetes in Europe reduced. Journal of Advanced Nursing. 26(2):221, 1997 Aug.

Alberti KG. The costs of non-insulin-dependent diabetes mellitus. [Editorial] Diabetic Medicine 14(1):7-9, 1997 Jan.

Arredondo A. Economical assessment of the epidemiological profile change; information for health care reforms [Spanish]. Revista Medica de Chile. 125(2):244-252, 1997 Feb.

Arredondo A, Damian T. Economic costs for the production of health services; from cost of inputs to cost of case-management [Spanish]. Salud Publica de Mexico. 39(2):117-124, 1997 Mar-Apr.

Arredondo A. Costs and financial consequences of the changing epidemiological profile in Mexico. Health Policy. 42(1):39-48, 1997 Oct.

Bienstock JL, Blakemore KJ, Wang E, Presser D, Misra D, Pressman EK. Managed care does not lower costs, but may result in poorer outcomes for patients with gestational diabetes. American Journal of Obstetrics & Gynecology. 177(5):1035-1037, 1997 Nov.

Bloomgarden ZT. More on managed care. [Review] Diabetes Care 20(2):227-31, 1997.

Boyer JG, Earp JA. The development of an instrument for assessing the quality of life of people with diabetes. Diabetes-39. Medical Care 35(5):440-53, 1997.

Bullimore SP, Keyworth C. Finding diabetics; a method of screening in general practice. British Journal of General Practice. 47(419):371-373, 1997 Jun.

Campbell LK, Campbell RK. Cost drivers in diabetes care; the problems they present and potential solutions. Clinical Therapeutics. 19(3):540-558, 1997 May-Jun.

Colwell JA. Controlling Type 2 diabetes; are the benefits worth the costs [Editorial]. Journal of the American Medical Association. 278(20):1700, 1997 Nov 26.

Costa B, Arroyo J, Sabate A. The economics of pharmacotherapy for diabetes mellitus [Review]. Pharmacoeconomics. 11(2):139-158, 1997 Feb.

Currie CJ, Peters JR. Estimation of unascertained diabetes prevalence; different effects on calculation of complication rates and resource utilization. Diabetic Medicine. 14(6):477-481, 1997 Jun.

Currie CJ, Morgan CL, Gill L, Stott NC, Peters JR. Epidemiology and costs of acute hospital care for cerebrovascular disease in diabetic and nondiabetic populations. Stroke 28(6):1142-6, 1997.

Currie CJ, Kraus D, Morgan CL, Gill L, Stott NCH, Peters JR. NHS acute sector expenditure for diabetes; the present, future, and excess in-patient cost of care. Diabetic Medicine. 14(8):686-692, 1997 Aug.

Currie CJ, Morgan CL, Peters JR. Patterns and costs of hospital care for coronary heart disease related and not related to diabetes. Heart. 78(6):544-549, 1997 Dec.

Davidson JA. The treatment of type II diabetes in Texas. Current issues for managed care and employers. [Meeting Report] Diabetes Care 20(3):446-51, 1997.

Eastman RC, Javitt JC, Herman WH, Dasbach EJ, Copley-Merriman C, Maier W, Dong F, Manninen D, Zbrozek AS, Kotsanos J, Garfield SA, Harris M. Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care 20(5):735-44, 1997.

Eastman RC. Is intensive glycemic control worth the expense?. Cleveland Clinic Journal of Medicine 64(8):410-3, 1997 Sep.

Ellrodt G, Cook DJ, Lee J, Cho M, Hunt D, Weingarten S. Evidence-based disease management. Journal of the American Medical Association. 278(20):1687-1692, 1997 Nov 26.

Friderichsen B, Maunsbach M. Glycosuric tests should not be employed in population screenings for NIDDM. Journal of Public Health Medicine. 19(1):55-60, 1997 Mar.

Gallichan M. Self monitoring of glucose by people with diabetes: evidence based practice. [Review] BMJ 314(7085):964-7, 1997.

Garattini L, Brunetti M, Salvioni F, Barosi M. Economic evaluation of ACE inhibitor treatment of nephropathy in patients with insulin-dependent diabetes mellitus in Italy. Pharmacoeconomics. 12(1):67-75, 1997 Jul.

Gilmer TP, Oconnor PJ, Manning WG, Rush WA. The cost to health plans of poor glycemic control. Diabetes Care. 20(12):1847-1853, 1997 Dec.

Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 20(4):562-7, 1997.

Glasgow RE, Lachance PA, Toobert DJ, Brown J, Hampson SE, Riddle MC. Long term effects and costs of brief behavioural dietary intervention for patients with diabetes delivered from the medical office. Patient Education & Counseling. 32(3):175-184, 1997 Nov.

Gruessner AC, Troppmann C, Sutherland DE, Gruessner RW. Donor and recipient risk factors significantly affect cost of pancreas transplants. Transplantation Proceedings 29(1-2):656-7, 1997.

Gulliford MC. Design of cost-effective packages of care for non-insulin-depdendent diabetes mellitus; defining the information needs. International Journal of Technology Assessment in Health Care. 13(3):395-410, 1997 Sum.

Gunning D. Practice compared. The UK and Australia. Australian Family Physician 26(6):697-701, 1997.

Hart WM, Espinosa C, Rovira J. A simulation model of the cost of the incidence of IDDM in Spain. Diabetologia 40(3):311-8, 1997.

Hart WM, Espinosa C, Rovira J. Cost of known diabetes mellitus in Spain [Spanish]. Medicina Clinica. 109(8):289-293, 1997 Sep 13.

Hasche H. What is the cost of type II diabetic patients? ... Expensive when treated, a fortune when untreated. [German] Fortschritte der Medizin 115(35-36):43-4, 1997 Dec 20.

Haupt E, Herrmann R, Benecke-Timp A, Vogel H, Haupt A, Walter C. The KID study IV: effects of inpatient rehabilitation on the frequency of glucose self-monitoring, quality of further primary care, on time being unable to work and on everyday psychic strain of type I and type II diabetics--a one-year follow-up. Kissingen Diabetes Intervention Study. Experimental & Clinical Endocrinology & Diabetes 105(1):21-31, 1997.

Hendry BM, Viberti GC, Hummel S, Bagust A, Piercy J. Modelling and costing the consequences of using an ACE inhibitor to slow the progression of renal failure in Type I diabetic patients. Qjm-Monthly Journal of the Association of Physicians. 90(4):277-282, 1997 Apr.

Herman WH, Dasbach EJ, Songer T, Eastman R, Nathan DM. Cost-effectiveness of intensive insulin therapy in the DCCT - Reply. [Letter] Journal of the American Medical Association. 277(5):374-375, 1997 Feb 5.

Herman WH, Dasbach EJ, Songer TJ, Eastman RC. The cost-effectiveness of intensive therapy for diabetes mellitus. Endocrinology & Metabolism Clinics of North America. 26(3):679 ff., 1997 Sep.

Hlatky MA, Rogers WJ, Johnstone I, Boothroyd D, Brooks MM, Pitt B, Reeder G, Ryan T, Smith H, Whitlow P, Wiens R, Mark DB. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. New England Journal of Medicine 336(2):92-9, 1997.

Ireys HT, Anderson GF, Shaffer TJ, Neff JM. Expenditures for care of children with chronic illnesses enrolled in the Washington state Medicaid program, Fiscal year 1993. Pediatrics. 100(2 Part 1):197-204, 1997 Aug.

Javor KA, Kotsanos JG, McDonald RC, Baron AD, Kesterson JG, Tierney WM. Diabetic ketoacidosis charges relative to medical charges of adult patients with type I diabetes. Diabetes Care 20(3):349-54, 1997.

Jiwa F. Diabetes in the 1990s--an overview. [Review] Statistical Bulletin - Metropolitan Insurance Companies 78(1):2-8, 1997 Jan-Mar.

Jonsson B. Smith U. Good diabetic control is worthwhile. [Swedish] Lakartidningen 94(34):2803-4, 1997 Aug 20.

Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Acute stroke care and rehabilitation: an analysis of the direct cost and its clinical and social determinants. The Copenhagen Stroke Study. Stroke 28(6):1138-41, 1997.

Jovanovic-Peterson L, Bevier W, Peterson CM. The Santa Barbara County Health Care Services Program; birth weight change concomitant with screening for and treatment of glucose-intolerance of pregnancy; a potential cost-effective intervention. American Journal of Perinatology. 14(4):221-228, 1997 Apr.

Kotsanos JG. Development of performance measures for seven chronic diseases. Health Outcomes Work Group of the Pharmaceutical Research and Manufacturers of America. Joint Commission Journal on Quality Improvement 23(3):150-61, 1997.

Legorreta AP, Hasan MM, Peters AL, Pelletier KR, Leung KM. An intervention for enhancing compliance with screening recommendations for diabetic retinopathy. A bicoastal experience. Diabetes Care 20(4):520-3, 1997.

Licciardone JC, Kotsanos JG, Brinkmankaplan V, Cooper T, Jordan JE, Wishner KL. Resource utilization and work or school loss reported by patients with diabetes; experience in diabetes training programs. American Journal of Managed Care. 3(5):777-782, 1997 May.

McClellan WM, Knight DF, Karp H, Brown WW. Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: important differences between practice and published guidelines. American Journal of Kidney Diseases 29(3):368-75, 1997 Mar.

McKinnon PS, Paladino JA, Grayson ML, Gibbons GW, Karchmer AW. Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clinical Infectious Diseases 24(1):57-63, 1997 Jan.

Moses R, Fulwood S, Griffiths R. Gestational diabetes mellitus resource utilization and costs of diagnosis and treatment. Australian & New Zealand Journal of Obstetrics & Gynaecology. 37(2):184-186, 1997 May.

Munroe WP, Kunz K, Dalmady-Israel C, Potter L, Schonfeld WH. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clinical Therapeutics 19(1):113-23, 1997.

Narayan KM. Cost-effectiveness of intensive insulin therapy in the Diabetes Control and Complications Trial [Letter]. JAMA 277(5):374-5, 1997 Feb 5.

Narayan KMV. Diabetes mellitus in native americans; the problem and its implications [Review]. Population Research & Policy Review. 16(1-2):169-192, 1997 Apr.

Oki JC, Flora DL, Isley WL. Frequency and impact of SMBG on glycemic control in patients with NIDDM in an urban teaching hospital clinic. Diabetes Educator. 23(4):419-424, 1997 Jul-Aug.

Panayiotopoulos YP, Tyrrell MR, Arnold FJ, Korzon-Burakowska A, Amiel SA, Taylor PR. Results and cost analysis of distal [crural/pedal] arterial revascularisation for limb salvage in diabetic and non-diabetic patients. Diabetic Medicine 14(3):214-20, 1997.

Quickel KE Jr. Managed care and diabetes, with special attention to the issue of who should provide care. Transactions of the American Clinical & Climatological Association. 108:184-95; discussion 196-9, 1996.

Ragnarson-Tennvall G, Apelqvist J. Cost-effective management of diabetic foot ulcers; a review. Pharmacoeconomics. 12(1):42-53, 1997 Jul.

Ratner RE. Long-term health care outcomes in diabetes; economic and political implications. Endocrinology & Metabolism Clinics of North America. 26(3):487 ff., 1997 Sep.

Riordan JM. The cost of not breastfeeding: a commentary. Journal of Human Lactation. 13(2):93-7, 1997 Jun.

Roman SH, Harris MI. Management of diabetes mellitus from a public health perspective. Endocrinology & Metabolism Clinics of North America. 26(3):443 ff., 1997 Sep.

Ruggiero L, Glasgow R, Dryfoos JM, Rossi JS, Prochaska JO, Orleans CT, Prokhorov AV, Rossi SR, Greene GW, Reed GR, Kelly K, Chobanian L, Johnson S. Diabetes self-management. Self-reported recommendations and patterns in a large population. Diabetes Care 20(4):568-76, 1997.

Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 20(9):1396-1402, 1997.

Simeon G, Bakris GL. Socioeconomic impact of diabetic nephropathy; can we improve the outcome. Journal of Hypertension. 15(Suppl 2):S 77-S 82, 1997 Mar.

Songer TJ, LaPorte R, Lave JR, Dorman JS, Becker DJ. Health insurance and the financial impact of IDDM in families with a child with IDDM. Diabetes Care 20(4):577-84, 1997 Apr.

Su JC, Kemp AS, Varigos GA, Nolan TM. Atopic eczema: its impact on the family and financial cost. Archives of Disease in Childhood 76(2):159-62, 1997 Feb.

Swinburn B, Ashton T, Gillespie J, Cox B, Menon A, Simmons D, Birkbeck J. Health care costs of obesity in New Zealand. International Journal of Obesity. 21(10):891-896, 1997 Oct.

Tauber JP. Non-insulin dependent diabetes mellitus and quality of life [French]. Diabetes & Metabolism. 23(Suppl 4):44-48, 1997 Nov.

Taylor TN, Chrischilles EA. Economic evaluation of interventions in endocrinology. [Review] Endocrinology & Metabolism Clinics of North America 26(1):67-87, 1997 Mar.

Tennvall GR. Rosenqvist U. Nilsson LG. It is worth concentrating on prevention of complications. An example from diabetic care. [Swedish] Lakartidningen 94(34):2817-21, 1997 Aug 20.

Tovi J, Furhoff AK, Lennerhagen P, Engfeldt P. Starting insulin therapy in elderly non-insulin-dependent diabetic patients at a health care centre; methodological and economic aspects. Scandinavian Journal of Primary Health Care. 15(2):87-91, 1997 Jun.

von Ferber L, Koster I, Hauner H. A cost of illness study of diabetes mellitus. [German] Gesundheitswesen 59(1):17-22, 1997 Jan.

Wandell PE, Brorsson B, Aberg H. Psychic and socioeconomic consequences with diabetes compared to other chronic conditions. Scandinavian Journal of Social Medicine 25(1):39-43, 1997.


Anonymous. Model for state insurance legislation would secure reimbursement for medical nutrition therapy for diabetes. Journal of the American Dietetic Association 96(5):446, 1996 May.

Adab P. Screening for sight threatening eye disease. Cost effectiveness of screening modalities must be determined [letter]. BMJ 312(7028):440; discussion 440-1, 1996 Feb 17.

Bloomgarden ZT. American Diabetes Association annual meeting 1996: managed care and change in medicine. [Meeting Report] Diabetes Care 19(10):1169-73, 1996 Oct.

Boult C, Altmann M, Gilbertson D, Yu C, Kane RL. Decreasing Disability in the 21st Century - The future effects of controlling six fatal and nonfatal conditions. American Journal of Public Health 86(10):1388-1393, 1996.

Bowman L. Using national and institutional economic data to target most cost-effective use of abciximab. Formulary 1996;31:186-: (PN).

Costa B, Estopa A, Borras J, Sabate A, Paez F. Medication consumption in diabetes mellitus - pharmacoeconomics and acceptation of hospital conversion to u100 insulin [Italian]. Medicina Clinica 106(13):481-485, 1996.

Croll SD, Nicholas GG, Osborne MA, Wasser TE, Jones S. Role of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections. Journal of Vascular Surgery 24(2):266-70, 1996 Aug.

Currie CJ, Williams DRR, Peters JR. Patterns of in and outpatient activity for diabetes - a district survey. Diabetic Medicine 1996;13:273-280.

Currie C, Peters J. Costs of insulin-dependent diabetes mellitus [letter;comment]. Diabetic Medicine 13(7):684-5, 1996 Jul.

Day JL, Bodmer CW, Dunn OM. Development of a questionnaire identifying factors responsible for successful self-management of insulin-treated diabetes. Diabetic Medicine 13(6):564-573, 1996.

The DCCT Research Group. Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Diabetes Control and Complications Trial. JAMA 276:1409-1415, 1996.

Deleiva A. Cost/benefits of intervention in pre-diabetes type I (Insulin-dependent). Diabetes, Nutrition & Metabolism - Clinical & Experimental. 9(6):315-318, 1996 Dec.

Eccles MP, Soutter J, Bateman DN, Campbell M, Smith JM. Influences on prescribing in non-fundholding general practices. Brit. J General Practice 1996;46:287-290.

Elixhauser A, Kitzmiller JL, Weschler JM. Short-term cost benefit of pre-conception care for diabetes. [Letter] Diabetes Care 19(4):384, 1996

Ernst K. From the president: a tale of cost containment and chronic disease. Diabetes Educator 22(2):103, 1996 Mar-Apr.

Fernando D. Costs of insulin injection [letter]. Ceylon Medical Journal 41(1):29-30, 1996 Mar.

Ford EJ, Remington PL. The burden of diabetes: the cost of diabetes hospitalizations in Wisconsin, 1994. Wisconsin Medical Journal 95(3):168-9, 1996 Mar.

Fore WW. Managed care approaches to diabetes mellitus. Hospital Practice (Office Edition). 31(7):115-7, 1996 Jul 15.

Gafni A. Economic-implications of IGT intervention - the case of a phantom alternative. Diabetic Medicine 1996;13:25-28.

Gill GV, Lishman M, Kaczmarczyk E, Tesfaye S. Targeted screening for diabetes in community chiropody clinics. QJM-Monthly Journal of the Association of Physicians 1996;89:229-232.

Glasgow RE, LaChance PA, Toobert D, Calder D, Farmer J, Hampson S. Long-term effects and costs of a brief behavioral intervention to change dietary behavior delivered in the medical office. Diabetes 1996;45[2]:43 (Abstract).

Gorsky RD, Pamuk E, Williamson DF, Shaffer PA, Koplan JP. The 25-year health care,costs of women who remain overweight after 40 years of age. American Journal of Preventive Medicine 12(5):388-94, 1996 Sep-Oct.

Gruesser M, Hartmann P, Schlottmann N, Joergens V. Structured treatment and teaching programme for type 2 diabetic patients on conventional insulin treatment: evaluation of reimbursement policy. Patient Education & Counseling 29(1):123-30, 1996 Oct.

Gulliford MC, Alert CV, Mahabir D, Ariyanayagambaksh SM, Fraser HS, Picou DI. Diabetes Care in Middle-Income Countries; A Caribbean Case Study. Diabetic Medicine 13(6):574-581, 1996.

Haupt E, Herrmann R, Benecke-Timp A, Vogel H, Haupt A, Walter C. The KID Study. II: Socioeconomic baseline characteristics, psycho-social strain, standard of current medical care and education of the Federal Insurance for Salaried Employees' Institution (BfA) diabetic patients in inpatient rehabilitation. Kissingen Diabetes Intervention Study. Experimental & Clinical Endocrinology & Diabetes 104(5):378-86, 1996.

Haupt E, Herrmann R, Benecke-Timp A, Vogel H, Hilgenfeldt J, Haupt A, Walter C. The KID Study. I: Structural baseline characteristics of the Federal Insurance for Salaried Employees' Institution (BfA) diabetic patients in inpatient rehabilitation. Kissingen Diabetes Intervention Study. Experimental & Clinical Endocrinology & Diabetes 104(5):370-7, 1996.

Holohan TV. Cost-effectiveness modeling of simultaneous pancreas-kidney transplantation. International Journal of Technology Assessment in Health Care 12(3):416-24, 1996 Summer.

Hopkins KD. UK Report Highlights Real Cost of Diabetes. Lancet 348(9027):608, 1996.

Ingberg CM, Palmer M, Aman J, Larsson S. Social consequences of insulin-dependent diabetes mellitus are limited: a population-based comparison of young adult patients vs healthy controls. Diabetic Medicine 13(8):729-33, 1996 Aug.

Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Annals of Internal Medicine 1996; 124:164-169.

Javitt JC, Wang F, McBean AM, Wang Q, Metrick S, Glaser S. The use and costs of physician services for ophthalmic surgical procedures in 1988 and 1991. Ophthalmic Surgery & Lasers 27(7):575-582, 1996.

Joannou J, Kalk WJ, Mahomed I, Ntsepo S, Berzin M, Joffe BL, Raal FJ, Sachs E, Vandermerwe MT, Wing JR. Screening for diabetic retinopathy in South Africa with 60-degrees retinal color photography. J Internal Medicine 1996; 239:43-47.

Kangas T, Aro S, Koivisto VA, Salinto M, Laakso M, Reunanen A. Structure and costs of health-care of diabetic-patients in Finland. Diabetes Care 1996;19:494-497.

Koch B. Glucose monitoring as a guide to diabetes management - Critical Subject Review. Canadian Family Physician 42:1142 ff., 1996.

Laville M. Diabetes, dialysis, health costs. [French] [Editorial] Nephrologie 17(6):319-20, 1996.

Le Pen C, Petitjean P, Levy P, Hannedouche T. Economic evaluation of the contribution of captopril in the treatment of diabetic nephropathy:a cost-benefit approach. [Review] [French] Nephrologie 17(6):321-6, 1996.

Marshall CL, Bluestein M, Chapin C, Davis T, Gersten J, Harris C, Hodgin A, Larsen W, Rigberg H, Krishnaswami V, Darling B. Outpatient management of diabetes mellitus in five Arizona Medicare managed care plans. American Journal of Medical Quality 11(2):87-93, 1996.

Matz H, Falk M, Gottinger W, Kieselbach G. Cost-benefit analysis of diabetic eye disease. Ophthalmologica 210(6):348-53, 1996.

McGuire A. Economic analysis of diabetes. [Review] Journal of Diabetes & its Complications 10(3):149-50, 1996 May-Jun.

O'Connor PJ, Rush WA, Peterson J, Morben P, Cherney L, Keogh C, Lasch S. Continuous quality improvement can improve glycemic control for HMO patients with diabetes. Archives of Family Medicine 5(9):502-6, 1996 Oct.

Pascual JM. Gonzalez C. Dejuan S, Sanchez C, Sanchez B, Perez M. Economic impact of diabetes mellitus in hospital costs [Spanish]. Medicina Clinica 107(6):207-210, 1996.

Pogach L, Hawley G, Sawin C, Bates M, Scheibe H, Cutler F, Weinstock R, Zieve F. Diabetes-related pharmacy costs in the veterans health administration. Diabetes 1996;45[2]:24 (Abstract).

Powe NR, Weiner JP, Starfield B, Stuart M, Baker A, Steinwachs DM. Systemwide provider performance in a Medicaid program - profiling the care of patients with chronic illnesses. Medical Care 34(8):798-810, 1996.

Quickel KE. Diabetes in a managed care system. Annals of Internal Medicine 1996; 124:160-163.

Quickel KE Jr. Managed care and diabetes, with special attention to the issue of who should provide care. Transactions of the American Clinical & Climatological Association.108:184-95; discussion 196-9, 1996.

Ray NF, Thamer M, Taylor T, Fehrenbach SN, Ratner R. Hospitalization and Expenditures for the Treatment of General Medical Conditions among the US Diabetic Population in 1991. Journal of Clinical Endocrinology & Metabolism 81(10):3671-3679, 1996.

Rizzo JA, Abbott TA, Pashko S. Labour Productivity Effects of Prescribed Medicines for Chronically Ill Workers. Health Economics 5(3):249-265, 1996.

Rodby RA, Firth LM, Lewis EJ. An Economic Analysis of Captropril in the Treatment of Diabetic Nephropathy. Diabetes Care 19(10):1051-1061, 1996.

Schlottmann N, Grusser M, Hartmann P, Jorgens V. Cost effectiveness and evaluation of a structured therapy and education program for insulin-treated type II diabetic patients in Bradenburg. [German] Zeitschrift fur Arztliche Fortbildung 90(5):441-4, 1996 Aug.

Simell TT, Sintonen H, Hahl J, Simell OG. Costs of IDDM. PharmacoEconomics 1996; 9:24-38.

Sinacore DR. Total contact casting for diabetic neuropathic ulcers [Review]. Physical Therapy 76(3):296-301, 1996 Mar.

Spinas GA, Bretzel RG. Socioeconomic significance of inadequate diabetes management. [German] [Editorial] Therapeutische Umschau 53(12):881, 1996 Dec.

Stern Z, Levy R. Analysis of direct cost of standard compared with intensive insulin treatment of insulin-dependent diabetes mellitus and cost of complications. Acta Diabetol 1996; 33:48-52.

Tan GH, Nelson RL. Pharmacologic treatment options for non-insulin-dependent diabetes mellitus. Mayo Clinic Proceedings 71(8):763-8, 1996 Aug.

Thom TJ. Economic costs of neoplasms, arteriosclerosis, and diabetes in the United States. In Vivo 10(2):255-9, 1996 Mar-Apr.

von Ferber L, Koster I, Hauner H. Direct costs of ambulatory treatment of diabetes mellitus. Comparison of observed costs with estimated costs of adherence to the treatment standard. [German] Medizinische Klinik 91(12):802-8, 1996 Dec 15.

Warner DC, McCandless RR, De Nino LA, Cornell JE, Pugh JA, Marsh GM. Costs of diabetes in Texas, 1992. Diabetes Care 19(12):1416-9, 1996 Dec.

Waugh NR. Screening for diabetic retinopathy. True costs are different from those given in paper [Letter]. BMJ 312(7047):1670; discussion 1670-1, 1996 Jun 29.

Wishner KL. 1995 Presidential Address. Things will never be the same again. Diabetes 45(5):541-3, 1996 May.

Wolf AM. Colditz GA. Social and economic effects of body weight in the United States [Review]. American Journal of Clinical Nutrition 63(3 Suppl):466S-469S, 1996 Mar.

Wolffenbuttel BH, Sels JP, Rondas-Colbers GJ, Menheere PP, Nieuwenhuijzen Kruseman AC. Comparison of different insulin regimens in elderly patients with NIDDM. Diabetes Care 19(12):1326-32, 1996 Dec.

Wooldridge J, Bergeron J, Thornton C. Preventing diabetic foot disease: lessons from the Medicare therapeutic shoe demonstration. American Journal of Public Health 86(7):935-8, 1996 Jul.


Alsever RN: Specialist versus primary care: not an easy question. Physician Executive 1995; 21:39-41.

Apelqvist J, Ragnarsontennvall G, Larsson J: Topical treatment of diabetic foot ulcers: an economic analysis of treatment alternatives and strategies. Diabetic Medicine 1995; 12:123-128.

Arrendondo A, Damian T, Deicaza E. An approach to the study of health services costs in Mexico[Spanish]. Salud Publica de Mexico 1995; 37:437-445.

Busch-Sorensen M. Elphick AJ. Home PD. Thorsteinsson B. Diabetes care: a guideline to the facilities needed to support internationally endorsed standards. Diabetic Medicine 12(9):833-8, 1995 Sep.

Carey M. Diabetes guidelines, outcomes, and cost-effectiveness study: a protocol, prototype, and paradigm. [Review] Journal of the American Dietetic Association 95(9):976-8, 1995 Sep.

Casparie AF, Vanderwaal MAE: Differences in preferences between diabetic patients and diabetologists regarding quality of care a matter of continuity and efficiency of care. Diabetic Medicine 1995; 12:828-832.

Collins RW, Anderson JW: Medication cost savings associated with weight loss for obese non-insulin dependent diabetic men and women. Preventive Medicine 1995; 24:369-374.

Costa B. Estopa A. Borras J. Sabate A. [Diabetes and pharmacoeconomics. Efficiency of insulin injection methods available in Spain]. [Spanish] Atencion Primaria 16(7):391-6, 1995 Oct 31.

Crijns H. Casparie AF. Hendrikse F. [Future need of eye care for patients with diabetes mellitus, costs and effectiveness]. [Dutch] Nederlands Tijdschrift voor Geneeskunde 139(26):1336-41, 1995 Jul 1.

The DCCT Research Group. Resource utilization and cost of care in the DCCT. Diabetes Care 1995; 18(11):1468-78.

Diel R. Ahrens K. Talaulicar M. Jaeschke B. [Disability payments in diabetes mellitus in social security: what is necessary?]. [German] Gesundheitswesen 57(7):373-9, 1995 Jul.

Eckman MH, Greenfield S, Mackey WC, Wong JB, Kaplan S, Sullivan L, Dukes K, Pauker SG: Foot infections in diabetic patients. Decision and cost effectiveness analyses. JAMA 1995; 273:712-720.

Flint E: Changing care patterns. Diabetic education: cost-effectiveness need not reduce quality care. Australasian Nurses Journal 1995; 9:1Feb.

Franz MJ, Splett PL, Monk A, Barry B, McClain K, Weaver T, Upham P, Bergenstal R, Mazze RS: Cost effectiveness of medical nutrition therapy provided by dietitians for persons with NIDDM. Journal of the American Dietetic Association 1995; 95:1018-1024.

Gillam SJ, Ball M, Prasad M, Dunne H, Cohen S, Vafidis G. Investigation of benefits and costs of an ophthalmic outreach clinic in general practice. British J Gen Practice 1995; 45:649-652.

Glasgow RE: A practical model of diabetes management and education. Diabetes Care 1995; 18:117-126.

Glasgow RE, Toobert DJ, Hampson SE, Noell JW. A brief office-based intervention to facilitate diabetes dietary self-management. Health Education Research 1995;10:467-478.

Gray A, Fenn P, McGuire A. The cost of IDDM in England and Wales. Diabetic Medicine 1995; 12:1068-1076.

Greenfield S, Rogers W, Mangotich M, Carney MF, Tarlov AR. Outcomes of patients with hypertension and NIDDM treated by different systems and specialties; results from the Medical Outcomes Study. JAMA 1995; 274:1436-1444.

Gulliford MC: Controlling NIDDM in developing countries. International Journal of Epidemiology 1995; 24[1]:53-59.

Gulliford MC, Ariyanayagambaksh SM, Bickram L, Picou D, Mahabir D. Counting the cost of diabetic hospital admissions from a multiethnic population in Trinidad. Diabetic Medicine 1995; 12:1077-85.

Haas LB: Financing the care of diabetes mellitus in the 1990s. Diabetes Educator 1995; 16:88 Apr.

Home PD. Economics of diabetes care must move forwards (Commentary). Brit Med J 1995; 311:1599.

International Diabetes Federation. Diabetes Epidemic to Explode Worldwide. World Diabetes Day Warns Governments that Ignorance is the Key. IDF, Brussels, October 23, 1995

Kahn M. The Cost of Diabetes, Economics Working Paper, July 1995

Kegler MC, Lengerich EJ, Norman M, Sullivan L, Stoodt G: The burden of diabetes in North Carolina. North Carolina Medical Journal 1995; 56:141-144.

Kiberd BA, Jindal KK. Screening to prevent renal failure in insulin-dependent diabetic patients; an economic evaluation. Brit Med J 1995; 311:1595-99.

King H, Gruber W, Lander T. Implementing National Diabetes Programmes. Report of a WHO Meeting. WHO, Geneva, 1995, 78 pages

LaCroix A, Jacquemet S, Assal JP: Patients experiences with their disease learning from the differences and sharing the common problems. Patient Education and Counseling 1995; 26:301-312.

Lakhani Z: Diabetes in the developing world [letter; comment]. BMJ 1995; 310:403.

Larsson J, Apelqvist J: Towards less amputations in diabetic patients. Incidence, causes, cost, treatment, and prevention; a review. [Review]. Acta Orthopaedica Scandinavica 1995; 66:181-192.

Law AV, Pathak DS, Segraves AM, Weinstein CR, Arneson WH. Cost-effectiveness analyses of the conversion of patients with NIDDM from glipzide to glyburide and of the accompanying pharmacy follow-up clinic. Clinical Therapeutics 1995; 17:977-87.

Lazar HL, Fitzgerald C, Gross S, Heeren T, Aldea GS, Shemin RJ. Determinants of length of stay after coronary artery bypass graft surgery. Circulation 1995; 92:20-24.

Lebrun T. Marissal JP. Socioeconomic consequences of non-insulin-dependent diabetes mellitus. Diabetes-Metabolism Reviews 11 Suppl 1:S87-95, 1995 Sep.

Leese B: Diabetes mellitus and the St Vincent Declaration: the economic implications. PharmacoEconomics 1995; 7:292-307.

Lenisa L. Castoldi R. Socci C. Motta F. Ferrari G. Spotti D. Caldara R. Secchi A. Pozza G. Di Carlo V. Cost-effective treatment for diabetic end-stage renal disease: dialysis, kidney, or kidney-pancreas transplantation?. Transplantation Proceedings 27(6):3108-13, 1995 Dec.

Lenisa L. Castoldi R. Socci C. Motta F. Ferrari G. Pozza G. Di Carlo V. Cost analysis of kidney-pancreas and kidney-islet transplant. Transplantation Proceedings 27(6):3061-4, 1995 Dec.

Lewis GF: Diabetic dyslipidemia: a case for aggressive intervention in the absence of clinical trial and cost effectiveness data. [Review]. Canadian Journal of Cardiology 1995; 11 Suppl C:24C-28C.

Levy E. Levy P. Le Pen C. Basdevant A. The economic cost of obesity: the French situation. International Journal of Obesity & Related Metabolic Disorders 19(11):788-92, 1995 Nov.

Morrison WB. Schweitzer ME. Wapner KL. Hecht PJ. Gannon FH. Behm WR. Osteomyelitis in feet of diabetics: clinical accuracy, surgical utility, and cost-effectiveness of MR imaging. Radiology 196(2):557-64, 1995 Aug.

Parnaby-Price A. Screening for diabetic retinopathy. Adequate programme would save money [letter; comment]. BMJ 311(7014):1229; discussion 1231, 1995 Nov 4.

Peters AL, Davidson MB, Ossorio RC: Management of patients with diabetes by nurses with support of subspecialists. HMO Practice 1995;9:8-13.

Pieber TR, Holler A, Brunner GA, Schattenberg S, Schnedl WJ, Semlitsch B, Zapotoczky H, Krejs GJ: Diabetes treatment in Austria 5 years after the St. Vincent Declaration. Wiener Klinische Wochenschrift 1995; 107:451-456.

Pieber TR, Holler A, Siebenhofer A, Brunner GA, Semlitsch B, Schattenberg S, Zapotoczky H, Rainer W, Krejs GJ: Evaluation of a structured teaching and treatment program for type 2 diabetes in general practice in a rural area of Austria. Diabetic Medicine 1995; 12:349-354.

Piwernetz K, Home PD, Johansen KS, Kleinebreil L, Vermeij D, Storms GEMG, Gallego MR, Benedetti MM, Cowley C. DiabCare quality network in Europe telematics project within the St-Vincent Declaration - consensus meeting - vouliagmeni (Athens) Greece 28-29 March 1995. Diabetes Nutrition & Metabolism 1995;8:243-249.

Saunders J, Gibbins RL: Diabetes care: activity and costs [letter; comment]. Diabetic Medicine 1995; 6:645 Oct.

Simell T, Moren R, Keltikangasjarvinen L, Hakalax J, Simell O: Short term and long term initial stay in hospital of children with insulin dependent diabetes; adjustment of families after 2 years. Acta Paediatrica 1995; 84:41-50.

Slama G, Selam JL: [Prevention of late complications of insulin dependent diabetes. How far and at what price?]. [French]. Annales d Endocrinologie 1995; 56:31-35.

Steindel BS, Roe TR, Costin G, Carlson M, Kaufman FR: Continuous subcutaneous insulin infusion (CSII) in children and adolescents with chronic poorly controlled type 1 diabetes mellitus. Diabetes Research and Clinical Practice 1995; 27:199-204.

Thompson CJ. Leese GP. The evaluation of mobile screening for diabetic retinopathy. [Review] Scottish Medical Journal 40(1):5-7, 1995 Feb.

Valente LA, Nelson MS: Patient education for diabetic patients; an integral part of quality health care. Journal of the American Podiatric Medical Association 1995; 85:177-179.

Vanhoutum WH, Lavery LA, Harkless LB: The costs of diabetes related lower extremity amputations in the Netherlands. Diabetic Medicine 1995; 12:777-781.

Wagner EH. Population-based management of diabetes care. Patient Education & Counseling 26(1-3):225-30, 1995 Sep.

Weiner JP. Parente ST. Garnick DW. Fowles J. Lawthers AG. Palmer RH. Variation in office-based quality. A claims-based profile of care provided to Medicare patients with diabetes. JAMA 273(19):1503-8, 1995 May 17.

Wilson BE, Sharma A: Public cost and access to primary care for hyperglycemic emergencies, Clark County, Nevada. Journal of Community Health 1995; 20:249-256.

Wood D, Mayfield R, Hermayer K, Eagerton D, Arnold P, Vale S, Chitwood M, Lyons T, Colwell J: Intensive management of IDDM using the DCCT model in an academic center costs and benefits. Diabetes 1995; 44[1]:48 (Abstract).

York R, Brown LP: Women with diabetes during pregnancy socio-demographics, outcomes, and costs of care. Public Health Nursing 1995; 12:290-293.

Zweers EJ. [First-line adjustment of insulin in patients with type II diabetes mellitus; good results with minimal costs (letter)]. [Dutch] Nederlands Tijdschrift voor Geneeskunde 139(19):1000-1, 1995 May 13.


Anonymous. Continuing diabetes care: Rhode Island, 1991. MMWR Morbidity & Mortality Weekly Report 1994; 43:798-800.

Anonymous. Prevention of Diabetes Mellitus. Report of a WHO Study Group. Technical Report Series No. 844. WHO, Geneva, 1994, 100 pages

Anonymous. The cost and prevalence of diabetes [news]. Medical Interface 1994; 7:116-117.

Anonymous. Integrated care for diabetes: clinical, psychosocial, and economic evaluation. Diabetes Integrated Care Evaluation Team [see comments]. BMJ 1994; 308:1208-1212.

Apelqvist J, Ragnarsontennvall G, Persson U, Larsson J: Diabetic foot ulcers in a multidisciplinary setting: an economic analysis of primary healing and healing with amputation. Journal of Internal Medicine 1994; 235:463-471.

Bakker K, Dooren J: [A specialized outpatient foot clinic for diabetic patients decreases the number of amputations and is cost saving (see comments)]. [Dutch]. Nederlands Tijdschrift voor Geneeskunde 1994; 138:565-569.

Bloomgarden ZT: Diabetes and managed care. Diabetes Care 1994; 17:1552-1554.

Caddick SL, McKinnon M, Payne N, Ward TJ, Thornton Jones H, Kells J, Ward JD: Hospital admissions and social deprivation of patients with diabetes mellitus. Diabetic Medicine 1994; 11:981-983.

Conklin MS: Hospitals adopt intensive programs for diabetic patients to avoid high inpatient costs. Health Care Strategic Management 1994; 12:11-13.

Dasbach EJ: Can quality care be planned. Diabetes Care 1994; 17[1]:18-21.

Etzwiler DD: Diabetes translation. A blueprint for the future. [Review]. Diabetes Care 1994; 17 Suppl 1:1-4.

Faronato P, Debigontina G: A cost benefit analysis of 2 mass screening strategies for albuminuria in diabetic patients. Diabetes Nutrition & Metabolism 1994; 7:325-329.

Fishbein HA: Comments on the financing and care of diabetes. The impact of research on program success. Milbank Quarterly 1994; 72:701-704.

Fore WW: Reimbursement for diabetes self care training. The North Carolina experience. Diabetes Care 1994; 17:608-610.

Foster JE: Diabetes in the developing world [letter; comment]. BMJ 1994; 309:1375

Glauber H, Brown J: Impact of cardiovascular disease on health care utilization in a defined diabetic population. Journal of Clinical Epidemiology 1994; 47:1133-1142.

Goldman DL, Fulton JP, Perry DK, Donahue FA, Feldman JP, Buechner JS, Waters WJ, Jr. Activity reduction and disability among persons with diabetes. Rhode Island Medicine 1994; 77:120-121.

Haardt MJ, Selam JL, Slama G, Bethoux JP, Dorange C, Mace B, Ramaniche ML, Bruzzo F: A cost benefit comparison of intensive diabetes management with implantable pumps versus multiple subcutaneous injections in patients with type 1 diabetes. Diabetes Care 1994; 17:847-851.

Harris MI, Cowie CC, Eastman R: Health insurance coverage for adults with diabetes in the U.S. population. Diabetes Care 1994; 17:585-591.

Herman WH, Dasbach EJ: Diabetes, health insurance, and health care reform [comment]. Diabetes Care 1994; 17:611-613.

Hirata Y: Systems for the treatment of diabetes in Japan. [Review]. Diabetes Research & Clinical Practice 1994; 24 Suppl:S229-32.

Hutton J: The economics of treating obesity. PharmacoEconomics 1994; 5[1]:66-72.

Javitt JC, Aiello LP, Chiang YP, Ferris FL, Canner JK, Greenfield S: Preventive eye care in people with diabetes is cost saving to the federal government; implications for health care reform. Diabetes Care 1994; 17:909-917.

Kaplan SH, Greenfield S: Evaluation of new statewide health reform initiatives. Milbank Quarterly 1994; 72:695-699.

Le Floch JP: Cost-effectiveness of screening for microalbuminuria using immunochemical dipstick tests or laboratory assays in diabetic patients. Diabetic Medicine 1994; 11:349-356.

Mauldin PD, Becker ER, Phillips VL, Weintraub WS: Hospital resource utilization during coronary artery bypass surgery. Journal of Interventional Cardiology 1994; 7:379-384.

Mazze RS: A systems approach to diabetes care. Diabetes Care 1994; 17[1]:5-11.

Naji S, Cameron I, Russell I, Harvey R, Leng M, Mcleod K, Murchison L, Pearson D, Philip F, Williams M: Integrated care for diabetes: clinical, psychosocial, and economic evaluation. BMJ 1994; 308:1208-1212.

Olsson J, Persson U, Tollin C, Nilsson S, Melander A: Comparison of excess costs of care and production losses because of morbidity in diabetic patients. Diabetes Care 1994; 17:1257-1263.

Phillips M, del Rio I, Quiroz H: Opportunities for cost reduction in diabetic retinopathy treatment: case study from Mexico. Bulletin of the Pan American Health Organization 1994; 28:50-61.

Post D: [A specialized outpatient foot clinic for patients with diabetes decreases the number of amputations and is cost saving (letter; comment)]. [Dutch]. Nederlands Tijdschrift voor Geneeskunde 1994; 138:1093

Reiber GE: Who is at risk of limb loss and what to do about it? Journal of Rehabilitation Research & Development 1994; 31:357-362.

Rekik M, Abid M, Hachicha J, Abbes R, Moujahed M, Jarraya A: [Direct cost of the ambulatory management of diabetes at the outpatient clinic of the National Social Security Fund of Sfax (Tunisia)]. [French]. Bulletin of the World Health Organization 1994; 72:611-614.

Rubin RJ, Altman WM, Mendelson DN: Health care expenditures for people with diabetes mellitus, 1992. Journal of Clinical Endocrinology and Metabolism 1994; 78:809-817:(PN).

Segal L, Carter R, Zimmet P: The cost of obesity the Australian perspective. PharmacoEconomics 1994; 5[1]:45-52.

Siddons H: The cost of education [editorial]. Diabetic Medicine 1994; 11:239-240.

Smith LR, Milano CA, Molter BS, Elbeery JR, Sabiston DC, Smith PK: Preoperative determinants of postoperative costs associated with coronary artery bypass graft surgery. Circulation 1994; 90:124-128.

Solomon C, Vanrij AM, Barnett R, Packer SGK, Lewisbarned NJ: Amputations in the surgical budget. New Zealand Medical Journal 1994; 107:78-80.

Sousa AM: Benefits of dietitian home visits. Journal of the American Dietetic Association 1994; 94:1149-1151.

Starfield B, Powe NR, Weiner JR, Stuart M, Steinwachs D, Scholle SH, Gerstenberger A: Costs vs quality in different types of primary care settings. JAMA 1994; 272:1903-1908.

Starfield B: Primary care participants or gatekeepers. Diabetes Care 1994; 17[1]:12-17.

Starostina EG, Antsiferov M, Galstyan GR, Trautner C, Jorgens V, Bott U, Muhlhauser I, Berger M, Dedov II: Effectiveness and cost benefit analysis of intensive treatment and teaching programs for type 1 (insulin dependent) diabetes mellitus in Moscow; blood glucose versus urine glucose self monitoring. Diabetologia 1994; 37:170-176.

Stern Z, Levy R: The direct cost of type 1 diabetes mellitus in Israel. Diabetic Medicine 1994; 11:528-533.

Stuart ME: Redefining boundaries in the financing and care of diabetes: the Maryland experience. Milbank Quarterly 1994; 72:679-694.

Wilson P, Simmons D: The development of community orientated recommendations for diabetes care in south Auckland. South Auckland Community Diabetes Planning Group. New Zealand Medical Journal 1994; 107:456-459.

Wolf AM, Colditz GA: The cost of obesity: the United States perspective. PharmocoEconomics 1994; 5[1]:34-37.

Wooldridge J, Moreno L: Evaluation of the costs to medicare of covering therapeutic shoes for diabetic patients. Diabetes Care 1994; 17:541-547.


Anonymous. [The Economic Burden of Diabetes. Symposium proceedings. Paris, France, 14-15 January 1993]. [French]. Diabete et Metabolisme 1993; 19:473-545.

Assal JP, Albeanu A, Peterriesch B, Vaucher J: The cost of training a diabetic patient; effects on prevention of amputation [French]. Diabete & Metabolisme 1993; 19:491-495.

Astrup AV: [Food expenses of patients with diabetes mellitus (letter)]. [Danish]. Ugeskrift for Laeger 1993; 155:1312-1313.

Bentkover JD, Champion AH: Economic evaluation of alternative methods of treatment for diabetic foot ulcer patients: cost-effectiveness of platelet releasate and wound care clinics. Wounds 1993; 5(4):207-215.

Borch-Johnsen K, Wenzel H, Viberti GC, Mogensen CE: Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes. British Medical Journal 1993; 306:1722-1723.

Bouter KP, Storm AJ, de Groot RR, Uitslager R, Erkelens DW, Diepersloot RJ: The diabetic foot in Dutch hospitals: epidemiological features and clinical outcome. European Journal of Medicine 1993; 2:215-218.

Bradshaw JD, Benafield RB: Case management. Journal of the Arkansas Medical Society 1993; 89:596-597.

Chantelau E: Diabetes treatment in developing countries [letter; comment]. Lancet 1993; 342:620

Chukwuma C, Sr. Type I diabetic nephropathy: clinical characteristics and economic impact. [Review]. Journal of Diabetes & its Complications 1993; 7:15-27.

Costa B, Monclus JF, Huguet M: The consumption of medication in diabetes mellitus. 2. The use and loss of insulin; epidemiologic and socioeconomic interest. Medicina Clinica 1993; 100:241-244.

Dawson LY: Proposed Medicare changes not favorable for individuals with diabetes. Diabetes Care 1993; 16:1219-1221.

Eastman RC, Silverman R, Harris M, Javitt JC, Chiang YP, Gorden P: Lessening the Burden of Diabetes: Intervention Strategies. Diabetes Care 1993; 16:1095-1102.

Elixhauser A, Weschler JM, Kitzmiller JL, Marks JS, Bennert HW, Jr., Coustan DR, Gabbe SG, Herman WH, Kaufmann RC, Ogata ES, et al: Cost benefit analysis of preconception care for women with established diabetes mellitus. Diabetes Care 1993; 16:1146-1157.

Falkenberg M, Apelqvist J, Rosenqvist U, Lithner F: [Foot ulcers in patients with diabetes. Preventive measures reduce the number of amputations]. [Swedish]. Lakartidningen 1993; 90:4221-4224.

Fox-Ray N, Wills S, Thamer M: Direct and Indirect Costs of Diabetes in the United States in 1992. American Diabetes Association, Alexandria, VA, 1993; 127.

Gagliardino JJ, Olivera EM, Barragan H, Puppo RA: A simple economic evaluation model for selecting diabetes health care strategies. Diabetic Medicine 1993; 10:351-354.

Gibbons GW. Marcaccio EJ Jr. Burgess AM. Pomposelli FB Jr. Freeman DV. Campbell DR. Miller A. LoGerfo FW. Improved quality of diabetic foot care, 1984 vs 1990. Reduced length of stay and costs, insufficient reimbursement. Archives of Surgery 128(5):576-81, 1993 May.

Gregory KD, Kjos SL, Peters RK: Cost of non-insulin dependent diabetes in women with a history of gestational diabetes: implications for prevention. Obstetrics & Gynecology 1993; 81:782-786.

Grenier JL, Qafli M, Gross P: An educational center for the treatment of diabetes and nutritional diseases in Roubaix; results after 10 years of functioning as an alternative to hospital care. Diabete & Metabolisme 1993; 19:528-532.

Griffith SP, Freeman WL, Shaw CJ, Mitchell WH, Olden CR, Figgs LD, Kinyoun JL, Underwood DL, Will JC: Screening for diabetic retinopathy in a clinical setting: a comparison of direct ophthalmoscopy by primary care physicians with fundus photography. Journal of Family Practice 1993; 37:49-56.

Halimi S, Benhamou PY, Charras H: [Cost of the diabetic foot]. [French]. Diabete et Metabolisme 1993; 19:518-522.

Jorgens V: Cost benefit analysis of teaching and care programs in type 2 diabetes [French]. Diabete & Metabolisme 1993; 19:510-513.

Kim MI, Kim ES, Ryu HS, Chu SK, Lee KS, Lee CK: [A study on estimation of early discharge day for home health care and medical expense for inpatients]. [Korean]. Korean Journal of Nursing 1993; 2:1517-8; discussion 1798.

Kozousek V, Brown MG, Cottle R, Hicks VA, Langille DB, Dingle J: Use of ophthalmologic services by diabetic patients in Nova Scotia. Canadian Journal of Ophthalmology [Journal Canadien d Ophtalmologie] 1993; 28:7-10.

Kressmann JB: [Cost of treatment using portable infusion pumps for subcutaneous insulin. State of the experiment in Lyon]. [French]. Diabete et Metabolisme 1993; 19:503-505.

Leese GP. Ahmed S. Newton RW. Jung RT. Ellingford A. Baines P. Roxburgh S. Coleiro J. Use of mobile screening unit for diabetic retinopathy in rural and urban areas. BMJ 306(6871):187-9, 1993 Jan 16.

Lefton CK: ACE inhibitor slows onset of renal disease in diabetics by 50%. Nephrology News & Issues 1993; 7:8

Levy Marchal C: [Cost benefit of screening for type 1 diabetes. A futuristic scenario]. [French]. Diabete et Metabolisme 1993; 19:538-545.

Lichter PR: Incentives for healthcare screening [editorial; comment]. Ophthalmology 1993; 100:1435-1436.

May ME. Young C. King J. Resource utilization in treatment of diabetic ketoacidosis in adults. American Journal of the Medical Sciences 306(5):287-94, 1993 Nov.

Milone-Nuzzo PF: Third party reimbursement for home care of clients with diabetes. Diabetes Educator 1993; 19:513-516.

Nordberg BJ, Barlow MS, Chalew SA, McCarter RJ: Effect of third party reimbursement on use of services and indexes of management among indigent diabetic patients. Diabetes Care 1993; 16:1076-1080.

Passa P, Giraud S: [Cost of the treatments of arterial hypertension associated with diabetes]. [French]. Diabete et Metabolisme 1993; 19:523-527.

Peters AL, Davidson MB, Ziel FH: Cost effective screening for diabetic retinopathy using a nonmydriatic retinal camera in a prepaid health care setting. Diabetes Care 1993; 16:1193-1195.

Phillipou G, Seaborn CJ, Hooper J, Phillips PJ: Capillary blood glucose measurements in hospital inpatients using portable glucose meters. Australian and New Zealand Journal of Medicine 1993; 23:667-671.

Phillips CB, Patel MS, Cabaron Y: Utilization of health services by Aboriginal Australians with diabetes. Diabetes Research and Clinical Practice 1993; 20:231-239.

Rendell M, Kimmel DB, Bamisedun O, O'Donnell ET, Fulmer J: The health care status of the diabetic population as reflected by physician claims to a major insurer. Archives of Internal Medicine 1993; 153:1360-1366.

Selam JL, Haardt MJ, Berne C, Dorange C, Lanoe JL, Bethoux JP, Slama, G. [Cost benefits of intensive insulin therapy using injections, external pumps and implantable pumps]. [French]. Diabete et Metabolisme 1993; 19:506-509.

Simell T, Simell O, Sintonen H: The 1st two years of type 1 diabetes in children; length of the initial hospital stay affects costs but not effectiveness of care. Diabetic Medicine 1993; 10:855-862.

Simmons D: Diabetes and the cost of coronary heart disease [letter; comment]. New Zealand Medical Journal 1993; 106:462

Thompson C, McWilliams T, Scott D, Simmons D: Importance of diabetic foot admissions at Middlemore hospital. New Zealand Medical Journal 1993; 106:178-180.

Tobin CT: Can a nationwide policy for office based diabetes education be replicated in the United States? Diabetes Care 1993; 16:1526-1527.

Triomphe A: Economic analysis and public health: Why do we need economic evaluation applied to diabetes? What methods must we choose; cost effectiveness, cost utility, cost benefit? Are such studies useful in terms of public health? Diabete & Metabolisme 1993; 19:473-476.

Tunbridge FKE, Millar JP, Schofield PJ, Spencer JA, Young G, Home PD: Diabetes care in general practice; an approach to audit of process and outcome. British Journal of General Practice 1993; 43:291-295.

Vardi P, Weitzman S, Shavit T: [Cost of insulin dependent diabetes vs cost of its prevention]. [Hebrew]. Harefuah 1993; 128:281-285.

Vondeling H: Evaluation of argon laser treatment of diabetic retinopathy and its diffusion in The Netherlands. Health Policy 1993; 23:97-111.

Wareham NJ: Cost effectiveness of alternative methods for diabetic retinopathy screening [letter; comment]. Diabetes Care 1993; 16:844

Yeo KT, Fan R, Yong V: Meeting the challenge of diabetic blindness in the 90's. Singapore Medical Journal 1993; 34:128-130.


Anonymous. Financing the costs of diabetes mellitus in the 1990's. Proceedings of a symposium of the Second National Conference on Financing the Care of Diabetes Mellitus. Washington, D.C., 3-5 December 1989. Diabetes Care 1992; 15 Suppl 1:1-72.

Borch-Johnsen K: [Insulin dependent diabetes mellitus: improved prognosis and insurance outlook]. [Danish]. Nordisk Medicin 1992; 107:217-219.

Bransome ED, Jr. Financing the care of diabetes mellitus in the U.S.: Background, problems, and challenges. Diabetes Care 1992; 15 Suppl 1:1-5.

Bransome ED, Jr. Improving the financing of diabetes care in the 1990s. Recommendations of the 1989 conference. Diabetes Care 1992; 15 Suppl 1:66-72.

Centers for Disease Control. Economic Aspects of Diabetes Services and Education: Selected Annotations. Atlanta: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Center for Chronic Disease Prevention and Health Promotion, Division of Diabetes Translation, 1992. 82 pages.

Chale SS, Swai AB, Mujinja PG, McLarty DG: Must diabetes be a fatal disease in Africa? Study of costs of treatment. BMJ 1992; 304:1215-1218.

Clark CM, Jr., Kinney ED: Standards for the care of diabetes. Origins, uses and implications for third party payment. Diabetes Care 1992; 15 Suppl 1:10-14.

Drummond MF, Davies LM, Ferris FL, 3d. Assessing the costs and benefits of medical research: the diabetic retinopathy study. Social Science & Medicine 1992; 34:973-981.

Elixhauser A, Weschler JM, Kitzmiller JL, Bennert HW, Coustan DR, Gabbe SG, Herman W, Kaufmann RC, Ogata ES, Marks JS, et al: Financial implications of implementing standards of care for diabetes and pregnancy. [Review]. Diabetes Care 1992; 15 Suppl 1:22-28.

Fendrick A, Javitt JC. Chiang YP. Cost-effectiveness of the screening and treatment of diabetic retinopathy. International Journal of Technology Assessment in Health Care 1992; 8(4):694-707.

Geffner DL: Diabetes care in health maintenance organizations. [Review]. Diabetes Care 1992; 15 Suppl 1:44-50.

Glauber HS, Brown JB: Use of health maintenance organization data bases to study pharmacy resource usage in diabetes mellitus. Diabetes Care 1992; 15:870-876.

Homa Lowry J: Quality assurance issues. Diabetes Care 1992; 15 Suppl 1:51-53.

Koperski M: Systematic care of diabetic patients in one general practice: how much does it cost? British Journal of General Practice 1992; 42:370-372.

Korn AM: Case management and quality of care for diabetic patients. Diabetes Care 1992; 15 Suppl 1:59-61.

Lairson DR, Pugh JA, Kapadia AS, Lorimor RJ, Jacobson J, Velez R: Cost effectiveness of alternative methods for diabetic retinopathy screening [see comments]. Diabetes Care 1992; 15:1369-1377.

Lasker RD: Payment for diabetes care under the Medicare fee schedule. Diabetes Care 1992; 15 Suppl 1:62-65.

Lee PD: An outpatient focused program for childhood diabetes: design, implementation, and effectiveness [see comments]. Texas Medicine 1992; 88:64-68.

Leese B: The costs of diabetes and its complications. [Review]. Social Science & Medicine 1992; 35:1303-1310.

Mazze RS, Franz MJ, Monk A, Cooper N, Barry B, Weaver T, McClain K, Upham P, Haugen D, Bergenstal R: Methodologies for Field Testing and Cost Effectiveness Analysis: Practice Guidelines for Nutrition Care by Dietetics Practitioners for Outpatients with NIDDM. Journal of the American Dietetic Association 1992; 92:1139-1142.

Noyes MA, Carter BL, Helling DK, McCormick WC, Ramirez R: Evaluation of glipizide and glyburide in a health maintenance organization. Annals of Pharmacotherapy 1992; 26:1215-1220.

O'Malley BC: Medicare admission criteria for diabetes mellitus in Florida. Diabetes Care 1992; 15 Suppl 1:54-58.

Phillips DE, Mann JI: Diabetes inpatient utilisation, costs and data validity. Dunedin 1985-9 [see comments]. New Zealand Medical Journal 1992; 105:313-315.

Phillips M, Salmeron J: Diabetes in Mexico: a serious and growing problem. World Health Statistics Quarterly [Rapport Trimestriel de Statistiques Sanitaires Mondiales] 1992; 45:338-346.

Pugh JA, Tuley MR, Hazuda HP, Stern MP: The influence of outpatient insurance coverage on the microvascular complications of non-insulin dependent diabetes in Mexican Americans. Journal of Diabetes & its Complications 1992; 6:236-241.

Rand LI: Financial implications of implementing standards of care for diabetic eye disease. [Review]. Diabetes Care 1992; 15 Suppl 1:32-35.

Reiber GE: Diabetic foot care. Financial implications and practice guidelines. Diabetes Care 1992; 15 Suppl 1:29-31.

Reparaz L, Martinez I, Ligero JM, Landaluce M, Galindo A, Hernandez, A, Jimenez Cossio JA: [The epidemiology and cost effectiveness analysis of diabetic angiopathy in vascular surgery]. [Spanish]. Angiologia 1992; 44:225-233.

Scheffler RM, Feuchtbaum LB, Phibbs CS. Prevention: The Cost Effectiveness of the California Diabetes and Pregnancy Program. American Journal of Public Health 1992; 82:168-175.

Sculpher MJ, Buxton MJ, Ferguson BA, Spiegelhalter DJ, Kirby AJ. Screening for Diabetic Retinopathy: A Relative Cost Effectiveness Analysis of Alternative Modalities and Strategies. Health Economics 1992; 1:39-51.

Siegel JE, Krolewski AS, Warram JH, Weinstein MC: Cost effectiveness of screening and early treatment of nephropathy in patients with insulin dependent diabetes mellitus. Journal of the American Society of Nephrology 1992; 3:S11-19.

Simmons D: Diabetes inpatient utilisation, costs and data validity, Dunedin 1985-9 [letter; comment]. New Zealand Medical Journal 1992; 105:388

Songer TJ: The economic costs of NIDDM. Diabetes Metabolism Reviews 1992; 8:389-404.

Songer TJ, DeBerry K, LaPorte RE, Tuomilehto J: International comparisons of IDDM mortality. Clues to prevention and the role of diabetes care. Diabetes Care 1992; 15 Suppl 1:15-21.

Swanson M, Hull D, Bartus S, Schweizer R: Economic impact of non-compliance in kidney transplant recipients. Transplantation Proceedings 1992; 24:2722

Tobin CT: Third party reimbursement coverage for diabetes outpatient education programs. Diabetes Care 1992; 15 Suppl 1:41-43.

Travis LB: "Educating" the person with diabetes in an ambulatory setting [comment]. Texas Medicine 1992; 88:69-71.

Waller L, Ehnberg S, Welin L: [The diabetes nurse; a resource probably saving money and shortening the length of stay]. [Swedish]. Lakartidningen 1992; 89:2104-2105.

Wheeler ML, Warren-Boulton E: Diabetes patient education programs. Quality and reimbursement. [Review]. Diabetes Care 1992; 15 Suppl 1:36-40.


Anonymous. Diabetes mellitus; its economic impact [news]. Journal Oklahoma State Medical Association 1991; 84:30.

Anonymous. Economic cost of diabetes mellitus in Minnesota, 1988. MMWR Morbidity & Mortality Weekly Report 1991; 40:229-231.

Anonymous. Surveys show socioeconomic trends in diabetes. Hospitals 1991; 65:1-4.

Arzamastseva LV, Martynova MI: [Sociodemographic characteristics of the families of children with diabetes mellitus]. [Russian]. Pediatriia 1991; 10-14.

Bransome Jr., E: Economics of diabetes and access to care: The United States perspective. In Diabetes 1991, Proceedings of the 14th Congress of the International Diabetes Federation. Rifkin H, Colwell JA, Taylor SI (eds). Amsterdam: Elsevier Science Publishers B.V., 1991, pp. 839-842.

Dasbach EJ, Fryback DG, Newcomb PA, Klein R, Klein BE: Cost effectiveness of strategies for detecting diabetic retinopathy. Medical Care 1991; 29:20-39.

de Weerdt I, Visser AP, Kok GJ, de Weerdt O, van der Veen EA: Randomized controlled multicentre evaluation of an education programme for insulin treated diabetic patients: effects on metabolic control, quality of life, and costs of therapy. Diabetic Medicine 1991; 8:338-345.

Galindo FR. Economics of diabetes and access to care: The Mexican perspective. In Diabetes 1991, Proceedings of the 14th Congress of the International Diabetes Federation. Rifkin H, Colwell JA, Taylor SI (eds). Amsterdam: Elsevier Science Publishers B.V., 1991, pp. 843-846.

Geppert J, Splett PL: Summary document of nutrition intervention in diabetes. Journal of the American Dietetic Association 1991; Suppl:S27-30.

Jacobs J, Sena M, Fox N: The cost of hospitalization for the late complications of diabetes in the United States. Diabetic Medicine 1991; 8 Spec No:S23-9.

Javitt JC, Aiello LP, Bassi LJ, Chiang YP, Canner JK: Detecting and treating retinopathy in patients with type I diabetes mellitus. Savings associated with improved implementation of current guidelines. American Academy of Ophthalmology. Ophthalmology 1991; 98:1565-73; discussion 1574.

Mengistu M, Lungi Y, Mamo F: Inpatient or outpatient initiation of insulin therapy. Experience and cost effective analysis in a suboptimal clinical setting. Tropical & Geographical Medicine 1991; 43:180-183.

Olivera EM, Duhalde EP, Gagliardino JJ: Costs of temporary and permanent disability induced by diabetes. Diabetes Care 1991; 14:593-596.

Reiber GE, King H. Guidelines for the Development of a National Programme for Diabetes Mellitus. WHO, Geneva, 1991, 70 pages

Retchin SM, Preston J: Effects of cost containment on the care of elderly diabetics [see comments]. Archives of Internal Medicine 1991; 151:2244-2248.

Roesler J, Bishop D, Walseth J. Economic cost of diabetes mellitus--Minnesota, 1988. MMWR 40:229-231, 1991.

Sculpher MJ, Buxton MJ, Ferguson BA, Humphreys JE, Altman JF, Spiegelhalter DJ, Kirby AJ, Jacob JS, Bacon H, Dudbridge SB, Stead JW, Feest TG, Cheng H, Franklin SL, Courtney P, Talbot JF, Ahmed R, Dabbs TR. A Relative Cost Effectiveness Analysis of Different Methods of Screening for Diabetic Retinopathy. Diabetic Medicine 1991; 8:644-650.

Triomphe A: The socio-economic cost of diabetic complications in France. Diabetic Medicine 1991; 8 Spec No:S30-2.

Waine C: Diabetes and the NHS bill. Diabetic Medicine 1991; 8:285.

Warren BH, Nugent C: The effects of cost containment on the care of elderly diabetics [editorial; comment]. Archives of Internal Medicine 1991; 151:2146-2147.


Allan BT, DeLong ER, Feussner JR: Impact of glucose self monitoring on non-insulin treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing. Diabetes Care 1990; 13:1044-1050.

Damsgaard EM: Known diabetes and fasting hyperglycaemia in the elderly. Prevalence and economic impact upon health services. [Review]. Danish Medical Bulletin 1990; 37:530-546.

Hunt C: Worksheet to estimate program costs and savings. Diabetes Educator 1990; 16:282-283.

Javitt JC, Canner JK, Frank RG, Steinwachs DM, Sommer A: Detecting and treating retinopathy in patients with type I diabetes mellitus. A health policy model. Ophthalmology 1990; 97:483-94; discussion 494-5.

Panser LA, Naessens JM, Nobrega FT, Palumbo PJ, Ballard DJ: Utilization trends and risk factors for hospitalization in diabetes mellitus. Mayo Clinic Proceedings 1990; 65:1171-1184.

Peddicord M, Lyons A, Tobin C, Vinicor F: Third party reimbursement for diabetes mellitus; outpatient education: a year's progress. Diabetes Spectrum 1990; 3:9-12.

Songer TJ: Health services and costing in diabetes [editorial]. Medical Journal of Australia 1990; 152:115-117.

Sutton L, Plant AJ, Lyle DM: Services and cost of hospitalization for children and adolescents with insulin-dependent diabetes mellitus in New South Wales. Medical Journal of Australia 1990; 152:130-136.

Villiger U, Straumann M, Grimm JJ: [Social and economic aspects in diabetes mellitus]. [German]. Schweizerische Rundschau fur Medizin Praxis 1990; 79:1217-1220.

Weinberger M, Cowper PA, Kirkman MS, Vinicor F: Economic impact of diabetes mellitus in the elderly. Clinics in Geriatric Medicine 1990; 6:959-970.

Weinberger M: Hospitalizations for patients with diabetes mellitus: changing perspectives. Mayo Clinic Proceedings 1990; 65:1268-1271.


Anonymous. Diabetes mortality update. Statistical Bulletin Metropolitan Insurance Companies 1989; 70:24-34; discussion 35.

Elixhauser A: The cost effectiveness of preventive care for diabetes mellitus. Diabetes Spectrum 1989; 2:349-353.

Everett WD: Screening for gestational diabetes: an analysis of health benefits and costs. [Review]. American Journal of Preventive Medicine 1989; 5:38-43.

Fulton ML, Coulter SJ: Alternative means of patient education. Nursing Management 1989; 20:58-60.

Gerard K, Donaldson C, Maynard AK: The cost of diabetes. Diabetic Medicine 1989; 6:164-170.

Huse DM, Oster G, Killen AR, Lacey MJ, Colditz GA: The economic costs of non-insulin dependent diabetes mellitus. JAMA 1989; 262:2708-2713.

Javitt JC, Canner JK, Sommer A: Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. Ophthalmology 1989; 96:255-264.

Laing W, Williams R. Diabetes; a model for health care management. OHE Publications No. 92. London: Office of Health Economics, 1989, pp. 160.

Lebl J, Kolouskova S, Vavrinec J, Tikovska J, Snajderova M: [What do we owe the families of diabetic children?]. [Czech]. Ceskoslovenska Pediatrie 1989; 44:729-733.

Martinez NC, Deane DM: Impact of prospective payment on the role of the diabetes educator. Diabetes Educator 1989; 15:503-509.

McKendry JB: Direct costs of diabetes care: a survey in Ottawa, Ontario 1986. Canadian Journal of Public Health 1989; Revue Canadienne de:124-128.

Moren-Hybbinette I, Moritz U, Schersten B: Diabetes mellitus and disability pension. A descriptive study of all diabetic subjects granted disability pension in Sweden in 1980. Scandinavian Journal of Social Medicine 1989; 17:193-201.

Nicholas WC, Watson RL: Medical and financial implications of discontinuing a statewide free insulin program involving 3,720 people. Southern Medical Journal 1989; 82:13-17.

Ostendorf GM: [Comment on the article by R. Petzoldt, Bad Oeynhausen: Cost control in drug therapy of diabetes. [German]. Versicherungsmedizin 1989; 41:203-204.

Petzoldt R, Oeynhausen B: [Cost reduction in drug therapy of diabetes]. [German]. Versicherungsmedizin 1989; 41:74-77.

Smith DG, Harlan LC, Hawthorne VM: The charges for ESRD treatment of diabetics. Journal of Clinical Epidemiology 1989; 42:111-118.

Vaughan P, Gilson L, Mills A: Diabetes in developing countries: its importance for public health. Health Policy and Planning 1989; 4:97-109.

Vines E, Orozco Beltran D, Llovet JM, Cruz Blanes J, Tormo MD, Cortes, J. [A comparative economic study of a health center and its reference hospital: apropos of a case of diabetes mellitus (letter)]. [Spanish]. Atencion Primaria 1989; 6 Spec No:72

Waugh NR: Diabetes care: activity and costs [letter; comment] [see comments]. Diabetic Medicine 1989; 6:177-178.


Alexander WD: Diabetes care in a UK health region: activity, facilities and costs [see comments]. Diabetic Medicine 1988; 5:577-581.

Fox NA, Jacobs J: Direct and Indirect Costs of Diabetes in the United States in 1987. American Diabetes Association, Alexandria, VA, 1988.

Giordano BP: Health insurance restraints under guise of cost containment. Diabetes Educator 1988; 14:10-12.

Krosnick A: Economic impact of type II diabetes mellitus. [Review]. Primary Care; Clinics in Office Practice 1988; 15:423-432.

Munoz E, Thies H, Maesaka JK, Angus G, Goldstein J, Wise L: Diagnosis related groups, resource utilization, age, and outcome for hospitalized nephrology patients. American Journal of Kidney Diseases 1988; 11:481-488.

Narins BE, Narins RG: Clinical features and health care costs of diabetic nephropathy. [Review]. Diabetes Care 1988; 11:833-839.

Sacerdote AS: Impact of budget cuts on diabetic control in urban adult diabetes clinic. Diabetes Care 1988; 11:302-303.

Singer DE, Samet JH, Coley CM, Nathan DM: Screening for diabetes mellitus. [Review]. Annals of Internal Medicine 1988; 109:639-649.

Triomphe A, Flori YA, Costagliola D, Eschwege E: The cost of diabetes in France. Health Policy 1988; 9:39-48.

Weinberger M, Ault KA, Vinicor F: Prospective reimbursement and diabetes mellitus. Impact upon glycemic control and utilization of health services. Medical Care 1988; 26:77-83.


Bruce DG, Clark EM, Danesi GA, Campbell LV, Chisholm DJ: Outpatient initiation of insulin therapy in patients with diabetes mellitus. Medical Journal of Australia 1987; 146:19-22.

Clements RS, Jr., Bell DS, Benbarka A, Capper SA: Rapid insulin initiation in non-insulin dependent diabetes mellitus [published erratum appears in Am J Med 1987 Aug;83(2): A11]. American Journal of Medicine 1987; 82:415-420.

Isaacs RD, Scott DJ: Diabetic patient discharges from Middlemore Hospital in 1983. New Zealand Medical Journal 1987; 100:629-631.

Kaplan RM, Hartwell SL, Wilson DK, Wallace JP. Effects of Diet and Exercise Interventions on Control and Quality of Life in NIDDM. Journal of General Internal Medicine 1987; 2:220-228.

Taylor AK: Medical expenditures and insurance coverage for people with diabetes: estimates from the National Medical Care Expenditure Survey. Diabetes Care 1987; 10:87-94.

Zarate A, Cervantes Rangel J, Fajardo Ortiz G, Villalpando Hernandez S: [A national program for the detection and treatment of diabetes mellitus]. [Spanish]. Gaceta Medica de Mexico 1987; 123:203-211.


Allen AP, Tymms DJ, Leatherdale BA, Lloyd RS: Clinical and financial implications of a district scheme to provide plastic insulin syringes to diabetics. British Medical Journal Clinical Research Ed 1986; 292:1710-1711.

Besse MF: [Economic and social problems in childhood diabetes. "Help for young diabetics"]. [French]. Soins Gynecologie, Obstetrique, Puericulture, Pediatrie 1986; 31-34.

Binimelis Vidal J, Villabona Artero P, Ubeda Arbesuk J, Codina Marce, M, de la Torre Nieto W, de Leiva Hidalgo A: [Impact of an educational program on the metabolic control and health costs of diabetes mellitus]. [Spanish]. Medicina Clinica 1986; 87:221-223.

Bransome ED, Jr. Assessment of impact of Medicare Prospective Payment System on care of persons with diabetes mellitus. Diabetes Care 1986; 9:415-419.

Campbell RK: Pharmaceutical services for patients with diabetes. Module 1. Professional and economic impact of diabetes on pharmacy practice. American Pharmacy 1986; NS26:suppl 18.

Figuerola D: [Education of the diabetic and its repercussion on health expenditures]. [Spanish]. Medicina Clinica 1986; 87:237-239.

Gifford S, Zimmet P: A community approach to diabetes education in Australia; The Region 8 (Victoria) Diabetes Education and Control Program. Diabetes Research & Clinical Practice 1986; 2:105-112.

Gjemdal T, Jervell J: [Sociomedical aspects of diabetes mellitus]. [Norwegian]. Tidsskrift for Den Norske Laegeforening 1986; 106:2433-2434.

Jones RB, Hedley AJ: Adjusting followup intervals in a diabetic clinic: implications for costs and quality of care. Journal of the Royal College of Physicians of London 1986; 20:36-39.

Kaplan RM, Davis WK. Evaluating the Costs and Benefits of Outpatient Diabetes Education and Nutrition Counseling. Diabetes Care 1986; 9:81-86.

Muhlhauser I, Klemm AB, Boor B, Scholz V, Berger M: [Length of stay and length of work incapacity in patients with Type I diabetes. Effects of a diabetes treatment and education program]. [German]. Deutsche Medizinische Wochenschrift 1986; 111:854-857.

Weiner CP, Fraser MM, Burns JM, Schnoor D, Herrig J, Whitaker LA. Cost Efficacy of Routine Screening for Diabetes in Pregnancy: 1h versus 2h Specimen. Diabetes Care 1986; 9:255-259.


Anonymous. Closing the gap: the problem of diabetes mellitus in the United States. The Carter Center of Emory University. [Review]. Diabetes Care 1985; 8:391-406.

Benton GS, Kerstein MD. Cost Effectiveness of Early Digit Amputation in the Patient with Diabetes. Surgery, Gynecology & Obstetrics 1985; 161:523-524.

Bonheim R: Brother, Can you Spare $14 Billion? Diabetes Forecast 1985; 33-35.(Magazine Article)

Cooper GJ, Scott DJ: The cost of diabetes in south Auckland [letter]. New Zealand Medical Journal 1985; 98:113

Entmacher PS, Sinnock P, Bostic E, Harris MI. Economic Impact of Diabetes. In Diabetes in America, Diabetes Data Compiled 1984. National Diabetes Data Group, Washington, DC, US Government Printing Office, 1985, NIH Pub. No. 85-1468, pp 113.

Famuyiwa OO, Edozien EM, Ukoli CO: Social, cultural and economic factors in the management of diabetes mellitus in Nigeria. African Journal of Medicine & Medical Sciences 1985; 14:145-154.

Segal Polin S: Paying for Health Care: The High Cost of Diabetes. Clinical Diabetes 1985; 108-116.

Tobin CT: Cost concepts for diabetes educators: an introduction. Diabetes Educator 1985; 16:45-6 Dec.

Vange B: [Economic support for families with preschool children with chronic illness]. [Danish]. Ugeskrift for Laeger 1985; 147:4137-4142.


Nielsen NV: [Diabetic eye disease. Occurrence of diabetic eye disease and the resource consumption in early tracing and treatment of diabetics in Denmark with threatened sight]. [Danish]. Ugeskrift for Laeger 1984; 146:533-538.

Sinnock P, Bauer DW: Reimbursement issues in diabetes. Diabetes Care 1984; 7:291-296.


Dieterlen P, Dieterlen M, Lestradet H. Evaluation of the Cost of Caring for Diabetic Children (Consultations, Hospitalizations, Summer Camps, etc.). In Recent Progress in MedicoSocial Problems in Juvenile Diabetics. Pediatric and Adolescent Endocrinology, Vol. 11. Basel: Karger, 1983, pp. 151-153.

Hopper SV: Meeting the needs of the economically deprived diabetic. Nursing Clinics of North America 1983; 18:813-825.

Ibrahim M and Habibullah M. Diabetes Health Care: Health Economics and Health Cost. In Diabetes 1982, Proceedings of the 11th Congress of the International Diabetes Federation. Mngola EN (ed). Amsterdam: Excerpta Medica, 1983, pp. 403-406.

Johansson BL, Berg U, Broberger O, Thalme B: [Improved metabolic control, kidney function and health care economics are the results of treatment with insulin pump]. [Swedish]. Lakartidningen 1983; 80:3818-3820.

Jonsson B: Diabetes; the cost of illness and the cost of control. An estimate for Sweden 1978. Acta Medica Scandinavica Supplementum 1983; 671:19-27.

Kanemitsu T, Kanaoka R: [Outpatient nursing: report from Shioda Clinic. 11. Economic independence of a diabetic patient who was formerly receiving social welfare support]. [Japanese]. Kangogaku Zasshi Japanese Journal of Nursing 1983; 47:130-9

Lipsett LF. Economic Costs of Diabetes. In Recent Progress in Medico-Social Problems in Juvenile Diabetics. Pediatric and Adolescent Endocrinology, Volume 11. Basel: Karger. 1983, pp. 143-148.

Platt WG, and Sudovar SG. The Social and Economic Costs of Diabetes: An Estimate for 1979. Elkhart, IN:Home Health Care Group, Ames Division, Miles Laboratories, Inc., 1983, pp. 120.

Rosenbloom AL: Residential treatment centers in Europe for children and youth with diabetes mellitus. Clinical Pediatrics 1983; 22:760-763.

Ross DC: Self glucose monitoring. Alabama Journal of Medical Sciences 1983; 20:441-449.

Smeeding TM and Booton LA. Measuring and Valuing the Economic Benefits of Diabetes Control. Proceedings of the 19th National Meeting, Public Health Conference on Records and Statistics. Washington, DC, 1983, pp. 80-85.

Toublanc JE and Chaussain JL. Cost of Laboratory Examinations at Diagnosis and Followup in Diabetic Children in France. In Recent Progress in MedicoSocial Problems in Juvenile Diabetes. Pediatric Adolescent Endocrinology, Volume 11. Basel: Karger, 1983, pp. 154-155.

Tan MH, Wornell C, Ellis R: Diabetes mellitus in Prince Edward island. Tohoku Journal of Experimental Medicine 1983; 141 Suppl:301-307.

Varner MW: Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine 1983; 75:592-596.


Goldstein A, Elliott J, Lederman S, Worcester B, Russell P, Linzey, EM. Economic effects of self monitoring of blood glucose concentrations by women with insulin dependent diabetes during pregnancy. Journal of Reproductive Medicine 1982; 27:449-450.

Leichter SB, Hernandez C, Fisher A, Collins P, Courtney A: Diabetes in Kentucky. Diabetes Care 1982; 5:126-134.

Miller LV. SocioEconomic Impact of Diabetes Mellitus. In Brodoff, Bleicher (eds): Diabetes Mellitus and Obesity. Baltimore, Williams & Wilkins, 1982.

Octmares RE, Belio Blasco C, Jara Albarran A: [Work absenteeism and diabetes mellitus]. [Spanish]. Revista Clinica Espanola 1982; 165:91-94.

Savolainen EA, Lee QP: Diabetic retinopathy: need and demand for photocoagulation and its cost-effectiveness: evaluation based on services in the United Kingdom. Diabetologia 1982; 23:138-140.

Smith RB: Blood tests or urine tests in diabetes management? New Zealand Medical Journal 1982; 95:383

Thefeld W, Hoffmeister H: [Sociomedical aspects of diabetes mellitus]. [German]. Zfa Zeitschrift Fur Allgemeinmedizin 1982; 58:1396-1403.

Triomphe A, Lanoe JL, Costagliola D, Basdevant A, Eschwege E, Tchobroutsky G, Fardeau M: [Multidiscipline aspects and approach to the evaluation of care for diabetics]. [French]. Cahiers de Sociologie et de Demographie Medicales 1982; 22:5-21.


Anonymous. Impact of diabetes outpatient education program: Maine. MMWR Morbidity Mortality Weekly Report 1981; 31:307-308.

England WL, Roberts SD: Immunization to prevent insulin dependent diabetes mellitus? The economics of genetic screening and vaccination for diabetes. Annals of Internal Medicine 1981; 94:395-400.

Ghana Health Assessment Project Team: A Quantitative Method of Assessing the Health Impact of Different Diseases in Less Developed Countries. International Journal of Epidemiology 1981; 10:73-80.

Lower MG, Nordberg T: Diabetes education: report on financing and reimbursement. Diabetes Educator 1981; 7:24-27.

Policy Analysis, Inc. The Incidence Based Economic Costs of Diabetes Mellitus. In Evaluation of Cost of Illness Ascertainment Methodology. Part II: Applications of Methodology to Ascertain Lifetime Economic Costs of Illness in an Incidence Cohort. Hyattsville, MD: National Center for Health Statistics Contract No. 233792048, Dec 1981, pp. 4:14-59.

Tan MH, Wornell MC, Beck AW: Epidemiology of diabetes mellitus in Prince Edward Island. Diabetes Care 1981; 4:519-524.


Kuberski TT, Bennett PH: Diabetes mellitus as an emerging public health problem on Guam. Diabetes Care 1980; 3:235-241.

Laing WA. The Cost of diet related diseases. In Preventive Health and Nutrition, Proceedings of the 2nd Annual Conference of the British Nutrition Foundation. London: British Nutrition Foundation, 1980, pp. 55-75.


Anonymous. Outpatient 'coverage' for diabetics urged. US Medicine 1979; 15:33

Curchod B: [Education of the diabetic]. [French]. Revue Medicale de la Suisse Romande 1979; 99:415-417.

Ibrahim M. Therapeutic Dilemma Including Cost Effectiveness. In Diabetes 1979, Proceedings of the 10th Congress of the International Diabetes Federation. Waldhausl WK (ed). Amsterdam: Excerpta Medica, 1979, pp. 807-811.

Kuberski T, Bennett P. The status of diabetes mellitus in the territory of Guana. South Pacific Commission Information Document No. 47. 1979

Larsen DF: [Social medical problems in late diabetic manifestations]. [Danish]. Nordisk Medicin 1979; 94:298


Brouhard BH, Speegle D, Cunningham RJ, Gill S, Travis LB: Education of the child with juvenile onset diabetes mellitus: an example of cost containment. Texas Medicine 1978; 74:63-64.

Davidson JK: Diabetes patient education, third party payers, and Veterans Administration [editorial]. Diabetes Care 1978; 1:326-327.

Deckert T, Poulsen JE, Larsen M: Importance of Outpatient Supervision in the Prognosis of Juvenile Diabetes Mellitus: a Cost Benefit Analysis. Diabetes Care 1978; 1:281-284.

Hart IR: Insulins in New Zealand: a plea for rationalisation. New Zealand Medical Journal 1978; 88:248-250.

Larsen DF: [Economic problems of insulin dependent diabetics]. [Danish]. Ugeskrift for Laeger 1978; 140:2338-2340.


Algvere P: [New methods of treating eye complications in diabetes patients]. [Swedish]. Nordisk Medicin 1977; 92:231-232.

Smith RB: Why educate the diabetic? New Zealand Medical Journal 1977; 86:275-277.


Entmacher PS. Report of the Workgroup on the Economic Impact of Diabetes. In Report of the National Commission of Diabetes: Scope and Impact of Diabetes. Washington, DC: US Government Printing Office, 1976, pp. 305-351.


Werner JL, Tokuhata GK: Diabetes Mellitus: Its Annual Cost in Pennsylvania and the United States, 1975. 57 p, 1975; [NTIS HRP0006964].


Childhood Diabetes Mellitus. In Sultz HA, Schlesinger ER, Mosher WE, Feldman JG (eds): LongTerm Childhood Illness. Pittsburgh, PA, University of Pittsburgh Press, 1972, pp 223-248.